Data / Research funding / Rare Diseases
Rare Diseases: 20,120 NIH awards ($25.6B) to 1,561 organizations
20,120 NIH awards ($25.6B) in the NIH spending category Rare Diseases, to 1,561 organizations, read 2026-11-04. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 20,120 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $472,070,715 | December 1, 2024 | November 30, 2025 | CURRIER, JUDITH S. | reporter.nih.gov |
| HIV Vaccines Clinical Trials Network Leadership and Operations Center | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $244,071,463 | June 29, 2006 | November 30, 2027 | COREY, LAWRENCE | reporter.nih.gov |
| HIV Vaccine Trials Network Laboratory Center | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $177,480,054 | June 29, 2006 | November 30, 2027 | MCELRATH, MARGARET JULIANA | reporter.nih.gov |
| COG NCTN Year 12 BIQSFP Progress Report | NIH | National Cancer Institute | 2021 to 2025 | $141,250,012 | April 11, 2014 | February 28, 2026 | HAWKINS, DOUGLAS S. | reporter.nih.gov |
| Statistical and Data Management Center (SDMC), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $84,840,845 | June 29, 2006 | November 30, 2027 | HUGHES, MICHAEL DAVID | reporter.nih.gov |
| IMPAACT Leadership Group | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $77,468,129 | December 1, 2024 | November 30, 2027 | NACHMAN, SHARON A | reporter.nih.gov |
| Pediatric HIV/AIDS Cohort Study (PHACS) 2020 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $71,153,847 | September 18, 2020 | July 31, 2026 | WILLIAMS, PAIGE L | reporter.nih.gov |
| NCI Early Career Cancer Clinical Investigator Award | NIH | National Cancer Institute | 2021 to 2025 | $65,560,307 | March 10, 1997 | November 30, 2026 | EBERT, BENJAMIN LEVINE | reporter.nih.gov |
| Alliance for Clinical Trials in Oncology Operations Center - GY11 BIQSFP Funded Extension | NIH | National Cancer Institute | 2021 to 2025 | $65,300,792 | April 17, 2014 | February 28, 2026 | PIANTADOSI, STEVEN | reporter.nih.gov |
| Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $61,029,344 | September 30, 2019 | March 31, 2027 | URDAHL, KEVIN | reporter.nih.gov |
| SDMC - IMPAACT Leadership Group | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $59,233,299 | June 29, 2006 | November 30, 2027 | SHAPIRO, DAVID ERIC | reporter.nih.gov |
| ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) | NIH | National Institute on Aging | 2021 to 2025 | $56,766,232 | September 15, 2019 | August 31, 2030 | BOEVE, BRADLEY F | reporter.nih.gov |
| AIDS Clinical Trial Group Laboratory Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $56,714,107 | January 1, 2014 | November 30, 2027 | ALDROVANDI, GRACE M | reporter.nih.gov |
| NRG Oncology NCORP Research Base-BIQSFP | NIH | National Cancer Institute | 2021 to 2025 | $54,340,726 | July 11, 2025 | July 31, 2026 | BRUNER, DEBORAH WATKINS | reporter.nih.gov |
| Access for All in ALS (ALL ALS) West Clinical Coordinating Center | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $51,203,440 | September 25, 2023 | June 30, 2027 | BOWSER, ROBERT P | reporter.nih.gov |
| Access for All in ALS (ALL ALS) East Clinical Coordinating Center | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $49,098,369 | September 25, 2023 | June 30, 2027 | BERRY, JAMES DALE | reporter.nih.gov |
| Abramson Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $48,027,008 | January 15, 1997 | May 31, 2026 | VONDERHEIDE, ROBERT H. | reporter.nih.gov |
| Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $44,959,734 | August 13, 2025 | November 30, 2026 | KOTLOFF, KAREN L. | reporter.nih.gov |
| Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $38,435,039 | September 30, 2019 | September 29, 2026 | FORTUNE, SARAH | reporter.nih.gov |
| Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $35,184,139 | August 1, 2021 | July 31, 2026 | COLER, RHEA | reporter.nih.gov |
| COG Biospecimen Bank to Support NCI NCTN (U24) | NIH | National Cancer Institute | 2021 to 2025 | $34,059,058 | April 22, 2015 | March 31, 2027 | RAMIREZ MILAN, NILSA DEL CARMEN | reporter.nih.gov |
| Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $33,014,143 | September 25, 2023 | April 30, 2027 | BERRY, JAMES DALE | reporter.nih.gov |
| IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $32,128,916 | February 1, 2025 | January 31, 2026 | MILLIN, CHRISTINA | reporter.nih.gov |
| Children's Oncology Group | NIH | National Cancer Institute | 2023 to 2025 | $31,354,180 | March 1, 2023 | February 28, 2026 | ALONZO, TODD A | reporter.nih.gov |
| The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) | NIH | National Institute on Aging | 2024 to 2025 | $30,281,212 | August 15, 2024 | July 31, 2029 | BOXER, ADAM L. | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $29,642,385 | September 12, 1997 | November 30, 2025 | RATHMELL, WENDY KIMRYN | reporter.nih.gov |
| FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | NIH | National Cancer Institute | 2021 to 2025 | $29,487,084 | April 6, 2018 | September 15, 2026 | PORRAS, CAROLINA | reporter.nih.gov |
| Mayo Clinic Comprehensive Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $29,249,641 | April 25, 1997 | August 31, 2030 | WILLMAN, CHERYL LYNN | reporter.nih.gov |
| Task V15: Development of Assays and Reagents for mpox Vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $28,751,383 | September 1, 2022 | April 30, 2026 | RUDGE, THOMAS | reporter.nih.gov |
| An Intermediate-Size Expanded Access Protocol for Amyotrophic Lateral Sclerosis with Pridopidine | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $27,895,551 | September 25, 2023 | August 31, 2027 | PAGANONI, SABRINA | reporter.nih.gov |
| Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant | NIH | National Cancer Institute | 2021 to 2025 | $27,607,459 | June 1, 2025 | July 31, 2026 | ROTH, MICHAEL E. | reporter.nih.gov |
| Childhood Cancer Survivorship Study | NIH | National Cancer Institute | 2021 to 2025 | $27,522,831 | July 20, 1993 | November 30, 2026 | ARMSTRONG, GREGORY | reporter.nih.gov |
| Data Management and Coordinating Center: Rare Diseases Clinical Research Network | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $26,933,474 | August 5, 2019 | June 30, 2030 | MACALUSO, MAURIZIO | reporter.nih.gov |
| A non-viral CRISPR-mediated genome editing delivery platform as a potential therapy for neurogenetic diseases | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $26,526,303 | September 20, 2023 | July 31, 2027 | JIANG, YONG-HUI | reporter.nih.gov |
| Ola HAWAII | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $25,522,287 | September 23, 1997 | May 31, 2027 | HEDGES, JERRIS ROBERT | reporter.nih.gov |
| EO14042 DEVELOPMENT, STATISTICAL DESIGN, MONITORING AND COORDINATION OF VISION CLINICAL TRIALS AND EPIDEMIOLOGY RESEARCH | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $25,277,032 | November 1, 2021 | October 31, 2026 | MENEZES, SUPRIYA | reporter.nih.gov |
| University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $24,477,809 | February 1, 2007 | November 30, 2027 | ERON, JOSEPH J | reporter.nih.gov |
| Center without Walls for Imaging Proteinopathies with PET | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $24,457,384 | September 24, 2019 | July 31, 2029 | MACH, ROBERT H | reporter.nih.gov |
| AIDS and Cancer Specimen Resource (ACSR) | NIH | National Cancer Institute | 2021 to 2025 | $24,013,599 | September 23, 2013 | August 31, 2026 | BETHONY, JEFFREY MICHAEL | reporter.nih.gov |
| Vaccine and Treatment Evaluation Units | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $22,981,366 | December 11, 2019 | November 30, 2026 | ROUPHAEL, NADINE GEORGES | reporter.nih.gov |
| CCSG - Administrative Supplement - ECIA | NIH | National Cancer Institute | 2021 to 2025 | $22,920,176 | September 1, 1997 | March 31, 2029 | ODUNSI, KUNLE | reporter.nih.gov |
| Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS). | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $22,785,879 | September 25, 2023 | August 31, 2027 | ANDREWS, JINSY | reporter.nih.gov |
| MANUFACTURE OF CLINICAL GRADE EPSTEIN-BARR VIRUS VACCINE | NIH | National Cancer Institute | 2023 to 2025 | $22,579,077 | September 22, 2025 | September 21, 2027 | reporter.nih.gov | |
| Moffitt Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $22,007,955 | February 18, 1998 | January 31, 2027 | CLEVELAND, JOHN L. | reporter.nih.gov |
| UZ-UCSF CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $21,624,239 | September 9, 2025 | November 30, 2027 | CHIRENJE, ZVAVAHERA MIKE | reporter.nih.gov |
| Kids First Pediatric Data Resource Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $21,614,897 | September 1, 2025 | August 31, 2026 | RESNICK, ADAM CAIN | reporter.nih.gov |
| UCLA AIDS Prevention and Treatment Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $21,546,764 | February 1, 2007 | November 30, 2027 | LANDOVITZ, RAPHAEL J | reporter.nih.gov |
| Administrative Coordinating Center: Bench to Bassinet Program | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $21,378,391 | January 1, 2016 | December 31, 2025 | OLLBERDING, NICHOLAS J | reporter.nih.gov |
| Vaccine and Treatment Evaluation Unit at Saint Louis University | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $21,219,564 | December 11, 2019 | November 30, 2026 | HOFT, DANIEL F. | reporter.nih.gov |
| University of Arizona Cancer Center - Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $21,155,920 | July 1, 1997 | July 31, 2027 | THEODORESCU, DAN | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $20,980,807 | December 1, 1996 | February 28, 2029 | MAITRA, ANIRBAN | reporter.nih.gov |
| Nebraska Research Network in Functional Genomics | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $20,833,603 | September 30, 2001 | April 30, 2026 | SORGEN, PAUL L | reporter.nih.gov |
| Frontotemporal Dementia: Genes, Images, and Emotions | NIH | National Institute on Aging | 2021 to 2025 | $20,694,825 | September 1, 2002 | April 30, 2028 | GORNO TEMPINI, MARIA LUISA | reporter.nih.gov |
| ECOG-ACRIN Biospecimen Bank to Support NCTN | NIH | National Cancer Institute | 2021 to 2025 | $20,630,107 | April 29, 2015 | March 31, 2027 | JEWELL, SCOTT D | reporter.nih.gov |
| International Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $20,605,531 | January 1, 2014 | November 30, 2027 | ALDROVANDI, GRACE M | reporter.nih.gov |
| Specialized Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2024 | $20,560,271 | July 1, 1996 | April 30, 2026 | SIMEONE, DIANE M | reporter.nih.gov |
| West Virginia IDeA Network of Biomedical Research Excellence (WV-INBRE) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $20,261,619 | September 30, 2001 | July 31, 2029 | JOSHI, TRUPTI | reporter.nih.gov |
| Cure Sickle Cell | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $19,980,036 | September 28, 2018 | September 30, 2026 | EAPEN, MARY | reporter.nih.gov |
| South Carolina IDeA Networks of Biomedical Research Excellence (SC INBRE) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $19,943,827 | September 30, 2001 | August 31, 2026 | GOLDSMITH, EDIE C | reporter.nih.gov |
| Oklahoma IDeA Network of Biomedical Research Excellence | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $19,194,069 | September 6, 2001 | August 31, 2030 | LANG, MARK L | reporter.nih.gov |
| Baylor College of Medicine Cancer Center - Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $19,034,443 | July 1, 2007 | June 30, 2030 | REDDY, PAVAN | reporter.nih.gov |
| Louisiana Biomedical Research Network | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $18,867,890 | September 25, 2001 | April 30, 2030 | KOUSOULAS, KONSTANTIN G | reporter.nih.gov |
| Pediatric Brain Tumor Consortium A multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors | NIH | National Cancer Institute | 2021 to 2025 | $18,653,803 | April 1, 1999 | March 31, 2026 | ONAR-THOMAS, ARZU | reporter.nih.gov |
| An Expanded Access Protocol of Intravenous Trehalose Injection 90 mg/mL Treatment of Patients with Amyotrophic Lateral Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $18,136,504 | September 28, 2022 | August 31, 2025 | PAGANONI, SABRINA | reporter.nih.gov |
| UCSD Collaborative Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $18,116,542 | December 1, 2024 | November 30, 2027 | WILKIN, TIMOTHY J. | reporter.nih.gov |
| Guide RNA manufacturing capabilities for platform in vivo base editing therapies for metabolic liver diseases | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $17,556,074 | August 1, 2023 | July 31, 2028 | PERANTEAU, WILLIAM H. | reporter.nih.gov |
| The Indiana University-Ohio State University Maternal and Pediatric Precision in Therapeutics Data, Model, Knowledge, and Research Coordination Center (IU-OSU MPRINT DMKRCC) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $17,481,052 | September 10, 2021 | July 31, 2027 | QUINNEY, SARA K | reporter.nih.gov |
| East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional Consortium | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $17,134,028 | June 1, 2025 | June 30, 2026 | WOOLS-KALOUSTIAN, KARA KAY | reporter.nih.gov |
| Center for Quantitative Biology: A focus on "omics", from organisms to single cells | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $17,122,562 | August 1, 2019 | June 30, 2029 | WHITFIELD, MICHAEL L | reporter.nih.gov |
| Emory-CDC CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,972,899 | December 1, 2024 | November 30, 2027 | KELLEY, COLLEEN F | reporter.nih.gov |
| International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,840,939 | May 1, 2025 | April 30, 2027 | ROHNER, ELIANE | reporter.nih.gov |
| Center for Viral Systems Biology (CViSB) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,438,330 | February 1, 2018 | January 31, 2028 | ANDERSEN, KRISTIAN GRAUGAARD | reporter.nih.gov |
| Central Africa International Epidemiology databases to Evaluate AIDS | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,957,495 | May 1, 2025 | April 30, 2027 | YOTEBIENG, MARCEL | reporter.nih.gov |
| Transmission Aerobiology of M. tuberculosis: Genes and Metabolic Pathways That Sustain Mtb Across an Evolutionary Bottleneck | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,828,159 | May 13, 2021 | April 30, 2027 | RHEE, KYU Y | reporter.nih.gov |
| C3PO - The Candidate Clinical Correlate of Prognostic Outcome for TB Study | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $15,575,398 | July 1, 2024 | May 31, 2026 | NAHID, PAYAM | reporter.nih.gov |
| Therapeutic Editing to Lower PrP in Prion Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $15,507,691 | May 17, 2023 | April 30, 2026 | VALLABH, SONIA MINIKEL | reporter.nih.gov |
| PERU Clinical Trial Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,506,525 | December 1, 2024 | November 30, 2027 | SANCHEZ, JORGE LUIS | reporter.nih.gov |
| Pancreatitis-induced initiation of early onset pancreatic cancer | NIH | National Cancer Institute | 2021 to 2025 | $15,447,190 | February 1, 2025 | January 31, 2026 | SHAW, REUBEN | reporter.nih.gov |
| Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,404,946 | May 1, 2025 | June 30, 2026 | CASTILHO, JESSICA L | reporter.nih.gov |
| Life Course Cancer Epidemiology Cohort in Women | NIH | National Cancer Institute | 2021 to 2025 | $15,280,631 | June 1, 2013 | August 31, 2028 | ELIASSEN, A. HEATHER | reporter.nih.gov |
| Immune signatures of vaccine responses in vulnerable populations | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,275,325 | July 12, 2010 | April 30, 2028 | MONTGOMERY, RUTH R | reporter.nih.gov |
| NAC Attack, a phase-3, multicenter, randomized, placebo-controlled trial in patients with retinitis pigmentosa | NIH | National Eye Institute | 2022 to 2025 | $15,187,946 | March 17, 2022 | July 31, 2027 | KONG, XIANGRONG | reporter.nih.gov |
| University of Washington Vaccine and Treatment Evaluation Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,173,751 | December 11, 2019 | November 30, 2026 | WALD, ANNA | reporter.nih.gov |
| A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $15,144,108 | September 15, 2021 | August 31, 2027 | CLARDY, STACEY LYNN | reporter.nih.gov |
| PHRU-Setshaba Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,110,381 | December 1, 2024 | November 30, 2027 | GRAY, GLENDA E | reporter.nih.gov |
| Consolidated Basic Cancer Research Program | NIH | National Cancer Institute | 2021 to 2025 | $14,936,465 | April 1, 1997 | February 28, 2026 | ALTIERI, DARIO C | reporter.nih.gov |
| Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,843,451 | August 20, 2021 | May 31, 2028 | NAJI, ALI | reporter.nih.gov |
| Tracking and Engaging Disconnected Long-Term Survivors of Childhood Cancer to Improve Adherence to Evidence-Based Screening Guidelines | NIH | National Cancer Institute | 2021 to 2025 | $14,573,097 | September 5, 1997 | August 31, 2026 | SWEASY, JOANN B. | reporter.nih.gov |
| Task A90: Establishment of a Model of Nipah Virus Infection for Assessment of Medical Countermeasures Efficacy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,497,049 | April 15, 2024 | September 2, 2025 | BEASLEY, DAVID | reporter.nih.gov |
| Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $14,399,999 | March 26, 2024 | February 28, 2029 | SAVIC, RADOJKA | reporter.nih.gov |
| University of Rochester Vaccine and Treatment Evaluation Unit (VTEU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,263,529 | December 11, 2019 | November 30, 2026 | FALSEY, ANN R | reporter.nih.gov |
| Stanford Mendelian Genomics Research Center | NIH | National Human Genome Research Institute | 2021 to 2025 | $14,229,424 | July 15, 2021 | April 30, 2027 | MONTGOMERY, STEPHEN | reporter.nih.gov |
| Kaiser Washington Vaccine and Treatment Evaluation Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,173,633 | December 11, 2019 | November 30, 2026 | JACKSON, LISA A | reporter.nih.gov |
| Children's Oncology Group Pediatric Early Phase Clinical Trial Network | NIH | National Cancer Institute | 2021 to 2024 | $14,041,303 | May 3, 2024 | July 31, 2024 | WEIGEL, BRENDA J. | reporter.nih.gov |
| Admin. Supp.: Correction of Neurological Disease via Allele Specific Excision of Pathogenic Repeats | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $13,703,967 | May 15, 2023 | April 30, 2028 | DOUDNA, JENNIFER A | reporter.nih.gov |
| HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $13,518,599 | April 1, 2007 | November 30, 2027 | BEKKER, LINDA-GAIL | reporter.nih.gov |
| Metabolic determinants of Mtb virulence, vulnerability and variation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $13,485,680 | May 1, 2025 | April 30, 2027 | MOODY, DAVID BRANCH | reporter.nih.gov |
| CURE SICKLE CELL INITIATIVE DATA STRATEGY AND DATA RESOURCES PROGRAM | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $13,440,748 | September 28, 2018 | December 31, 2026 | KRONER, BARBARA L | reporter.nih.gov |
| Protective immunity following dengue virus natural infections and vaccination | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $13,429,941 | July 29, 2015 | July 31, 2030 | HARRIS, EVA | reporter.nih.gov |
| Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $13,418,019 | June 15, 2021 | May 31, 2027 | ALONSO, ESTELLA M. | reporter.nih.gov |
| University of Washington Mendelian Genomics Research Center (UW-MGRC) | NIH | National Human Genome Research Institute | 2021 to 2025 | $13,388,168 | June 1, 2021 | March 31, 2027 | WEI, CHIA-LIN | reporter.nih.gov |
| Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $13,340,237 | April 10, 2020 | November 30, 2026 | MULLIGAN, MARK JOSEPH | reporter.nih.gov |
| Vanderbilt HIV Clinical Trials Unit (CTU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,733,650 | February 1, 2007 | November 30, 2027 | HAAS, DAVID W | reporter.nih.gov |
| Case Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,725,521 | December 1, 2024 | November 30, 2027 | YENDEWA, GEORGE | reporter.nih.gov |
| NATIONAL CHILDHOOD CANCER REGISTRY (NCCR) | NIH | National Cancer Institute | 2021 to 2025 | $12,616,798 | July 1, 2022 | June 30, 2025 | KOHLER, BETSY | reporter.nih.gov |
| Respiratory pathogen-specific T cell signatures following vaccination, natural infection, and treatment | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,580,221 | June 1, 2025 | May 31, 2027 | SETTE, ALESSANDRO | reporter.nih.gov |
| Development of an Antiviral to Combat Viral Infections | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $12,480,276 | November 15, 2022 | April 17, 2025 | CHANG, JINHONG | reporter.nih.gov |
| Georgetown University Lombardi Comprehensive Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $12,475,608 | July 1, 2025 | June 30, 2026 | WEINER, LOUIS M. | reporter.nih.gov |
| Columbia Collaborative HIV/AIDS Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,286,513 | February 1, 2007 | November 30, 2027 | SOBIESZCZYK, MAGDALENA ELZBIETA | reporter.nih.gov |
| Broad Institute Mendelian Genomic Research Center | NIH | National Human Genome Research Institute | 2021 to 2025 | $12,228,086 | June 1, 2021 | March 31, 2027 | O'DONNELL-LURIA, ANNE | reporter.nih.gov |
| A Safety and Efficacy Study of AAV2-hAADC for AADC Deficiency | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $12,060,518 | September 15, 2016 | August 31, 2027 | BANKIEWICZ, KRYSTOF S | reporter.nih.gov |
| Center for Live Cell Genomics | NIH | National Human Genome Research Institute | 2021 to 2025 | $11,992,289 | September 15, 2021 | June 30, 2027 | HAUSSLER, DAVID H | reporter.nih.gov |
| A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $11,962,900 | September 30, 2021 | July 31, 2027 | LUCIANO, MARK GREGORY | reporter.nih.gov |
| Scalable Expanded Access with Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS (SEA-NOBI-ALS) | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $11,846,278 | September 1, 2024 | August 31, 2028 | OSKARSSON, BJORN E | reporter.nih.gov |
| (EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank | NIH | National Cancer Institute | 2021 to 2025 | $11,843,510 | September 1, 2020 | March 31, 2027 | NICOL, KATHLEEN | reporter.nih.gov |
| TB-RICC 3.0 | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $11,818,694 | April 1, 2023 | March 31, 2028 | ELLNER, JERROLD J. | reporter.nih.gov |
| Task A71: Comprehensive In Vivo Screening of Viral Pathogens of Pandemic Potential | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,745,278 | July 18, 2022 | July 17, 2025 | MORREY, JOHN | reporter.nih.gov |
| Baylor College of Medicine - Mendelian Genomics Research Center (BCM-MGRC) | NIH | National Human Genome Research Institute | 2021 to 2025 | $11,728,929 | July 15, 2021 | April 30, 2027 | GIBBS, RICHARD A | reporter.nih.gov |
| Center for Musculoskeletal Disease Research (CMDR) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $11,683,826 | February 16, 2018 | January 31, 2028 | O'BRIEN, CHARLES A | reporter.nih.gov |
| NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,660,249 | July 15, 2020 | October 31, 2025 | PHILLIPS, ELIZABETH | reporter.nih.gov |
| Development of an Optimized Adjuvanted TB Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $11,645,061 | September 30, 2021 | September 30, 2025 | EVANS, JAY | reporter.nih.gov |
| Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS). | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $11,639,047 | September 25, 2023 | August 31, 2027 | ANDREWS, JINSY | reporter.nih.gov |
| Cancer Center Support (CORE) Grant | NIH | National Cancer Institute | 2021 to 2025 | $11,628,123 | August 1, 1997 | June 30, 2030 | PALUCKA, ANNA KAROLINA | reporter.nih.gov |
| Cancer Research Consortium of West Michigan (CRCWM) | NIH | National Cancer Institute | 2021 to 2025 | $11,366,311 | August 8, 2014 | July 31, 2026 | BUTLER, KATHLEEN YOST | reporter.nih.gov |
| WaNPRC Macaca nemestrina SPF Breeding Colony | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $11,361,503 | September 30, 2002 | June 30, 2028 | FULLER, DEBORAH H. | reporter.nih.gov |
| Complement Mediated Remodeling in Pulmonary Vascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $11,355,302 | August 1, 2020 | June 30, 2026 | STENMARK, KURT R. | reporter.nih.gov |
| Characterizing pediatric genomes through an optimized sequencing approach | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $11,335,114 | September 23, 2016 | August 31, 2025 | GRIMWOOD, JANE | reporter.nih.gov |
| West African Emerging Infectious Disease Research Center (WA-EIDRC) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $11,322,650 | May 21, 2020 | June 5, 2025 | ANDERSEN, KRISTIAN GRAUGAARD | reporter.nih.gov |
| KwaZulu-Natal Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,302,268 | December 1, 2024 | November 30, 2027 | ABDOOL KARIM, QUARRAISHA | reporter.nih.gov |
| Pre-Symptomatic Familial ALS (Pre-fALS) Study: From Prodrome and Biomarkers to ALS/FTD Prevention | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $11,282,768 | September 15, 2018 | July 31, 2029 | BENATAR, MICHAEL | reporter.nih.gov |
| Center for Pre-Clinical Cancer Research | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $11,277,290 | March 1, 2021 | February 28, 2027 | FRANCIS, JOSEPH | reporter.nih.gov |
| A Follow-up Study for Causes of Cancer in Black Women | NIH | National Cancer Institute | 2021 to 2025 | $11,271,706 | September 21, 2012 | August 31, 2027 | PALMER, JULIE R | reporter.nih.gov |
| Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,202,199 | March 15, 2007 | September 21, 2025 | SANNE, IAN MATTHIAS | reporter.nih.gov |
| Mays Cancer Center at UT Health SA | NIH | National Cancer Institute | 2021 to 2025 | $11,193,809 | August 1, 1997 | July 31, 2026 | ZHENG, LEI | reporter.nih.gov |
| Multi-Scale Investigations of Respiratory Mucus/Mucin Structure and Function in Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $11,172,471 | August 15, 2022 | July 31, 2027 | BOUCHER, RICHARD CHARLES | reporter.nih.gov |
| Advancing Vaccine Adjuvant Research for Tuberculosis (TB) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $10,964,476 | September 30, 2022 | September 29, 2027 | BRITTON, WARWICK | reporter.nih.gov |
| Johns Hopkins University Baltimore India Clinical Trail Unit (JHUBI CTU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,947,708 | February 5, 2007 | November 30, 2027 | GUPTA, AMITA | reporter.nih.gov |
| Reagent Program for HIV and other Infectious Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $10,735,388 | October 15, 2023 | January 13, 2024 | RASHID, SUJATHA | reporter.nih.gov |
| Liver Cirrhosis Network: Scientific and Data Coordination Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $10,655,826 | August 28, 2021 | July 31, 2027 | SMITH, ABIGAIL | reporter.nih.gov |
| BCM CENTER FOR PRECISION MEDICINE MODELS | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $10,593,135 | September 15, 2020 | August 31, 2030 | HEANEY, JASON D. | reporter.nih.gov |
| Administrative Supplement Request for 2025 Systems Biology for Infectious Diseases Annual Meeting | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,511,156 | August 17, 2018 | May 31, 2028 | KROGAN, NEVAN J | reporter.nih.gov |
| SPORE in Brain Cancer | NIH | National Cancer Institute | 2021 to 2025 | $10,413,880 | September 1, 2008 | August 31, 2029 | LANG, FREDERICK F | reporter.nih.gov |
| Growth and development of Striatal-Cerebellum circuitry in subjects at risk for Huntington’s Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $10,413,314 | March 1, 2009 | August 31, 2026 | NOPOULOS, PEGGY C | reporter.nih.gov |
| Kansas Center for Metabolism and Obesity REsearch (KC-MORE) | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $10,233,525 | April 1, 2022 | February 28, 2027 | WEINMAN, STEVEN A | reporter.nih.gov |
| The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study | NIH | National Cancer Institute | 2021 to 2025 | $10,080,862 | June 23, 2015 | March 31, 2026 | CERHAN, JAMES R | reporter.nih.gov |
| Colorado Head and Neck Cancer SPORE | NIH | National Cancer Institute | 2021 to 2025 | $10,073,085 | September 1, 2021 | August 31, 2026 | JIMENO, ANTONIO | reporter.nih.gov |
| Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,070,868 | March 15, 2007 | November 30, 2027 | SUPPARATPINYO, KHUANCHAI | reporter.nih.gov |
| Southern Liver Health Cohort | NIH | National Cancer Institute | 2023 to 2025 | $10,038,112 | September 21, 2021 | August 31, 2027 | HOYO, CATHRINE | reporter.nih.gov |
| Advanced Development of a Multivalent Vaccine Candidate for Lassa Fever | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,931,387 | September 1, 2017 | January 31, 2027 | SCHNELL, MATTHIAS JOHANNES | reporter.nih.gov |
| The Military HIV Research Program (MHRP) Clinical Trial Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,910,676 | December 10, 2013 | November 30, 2027 | ROBB, MERLIN L | reporter.nih.gov |
| Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,824,534 | February 1, 2007 | June 30, 2025 | LOCKMAN, SHAHIN | reporter.nih.gov |
| Silence ALS: A Platform for the Discovery and Development of Antisense Therapeutics for Patients with Ultra-Rare Forms of ALS | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $9,796,602 | March 1, 2024 | February 28, 2027 | SHNEIDER, NEIL ALAN | reporter.nih.gov |
| Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $9,739,425 | September 1, 2022 | April 30, 2027 | GLADWIN, MARK T | reporter.nih.gov |
| Thalamocortical Responsive Neurostimulation for the Treatment of Lennox-Gastaut Syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,737,772 | June 1, 2021 | May 31, 2027 | MORRELL, MARTHA J | reporter.nih.gov |
| GHESKIO Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,655,243 | February 1, 2007 | November 30, 2027 | PAPE, JEAN WILLIAM | reporter.nih.gov |
| Chronic Pancreatitis Clinical Research Consortium (CPCRC) Data Coordinating Center (CPCRC-DCC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $9,632,234 | September 28, 2015 | June 30, 2030 | LI, LIANG | reporter.nih.gov |
| Aurora NCORP Community Site | NIH | National Cancer Institute | 2021 to 2025 | $9,617,195 | August 15, 2014 | July 31, 2026 | SAPHNER, THOMAS J | reporter.nih.gov |
| DEVELOPMENT OF UM-1098: A NOVEL SYNTHETIC TH17 INDUCING ADJUVANT AND DELIVERY SYSTEM | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $9,566,206 | September 30, 2023 | September 29, 2026 | EVANS, JAY | reporter.nih.gov |
| University of Washington Arboviral Research Network (UWARN) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $9,499,281 | May 22, 2020 | June 5, 2025 | VAN VOORHIS, WESLEY C | reporter.nih.gov |
| Targeting the A2B Adenosine Receptor for Immunoprevention of Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2025 | $9,423,468 | September 15, 2023 | March 14, 2027 | WU, XIANGWEI | reporter.nih.gov |
| Uncovering the Genetic Mechanisms of the Chromosome 17q21.31 Tau Haplotype on Neurodegeneration Risk in FTD and PSP | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,418,230 | September 1, 2021 | August 31, 2026 | GOATE, ALISON M | reporter.nih.gov |
| Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $9,412,704 | September 22, 2020 | June 30, 2026 | BURTNESS, BARBARA | reporter.nih.gov |
| Childhood Liver Disease Research Network (ChiLDReN) Scientific and Data Coordinating Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $9,404,513 | September 18, 2002 | May 31, 2029 | MAGEE, JOHN C | reporter.nih.gov |
| 1/2 Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $9,400,136 | September 1, 2020 | June 25, 2024 | MARTINEZ, FERNANDO J | reporter.nih.gov |
| MANAGEMENT AND RESEARCH SUPPORT FOR THE GENETIC AND RARE DISEASES (GARD) INFORMATION CENTER AND RELATED PROGRAMS. | NIH | National Institute on Drug Abuse | 2021 to 2023 | $9,359,953 | July 29, 2021 | July 28, 2024 | BALLEW, RICHARD | reporter.nih.gov |
| Development of a Novel Therapeutic for Melioidosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $9,235,577 | September 20, 2022 | September 30, 2026 | ALLEY, M.R.K. (DICKON) | reporter.nih.gov |
| Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $9,218,182 | August 24, 2022 | July 31, 2027 | BARKER, BRIDGET MARIE | reporter.nih.gov |
| COBRE: Eukaryotic Pathogens Innovation Center (EPIC) | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $9,118,734 | July 15, 2022 | May 31, 2027 | MORRIS, JAMES CULVIN | reporter.nih.gov |
| Identification of TDP-43 Modifiers Through Single-Cell Transcriptional and Epigenomic Dissection of ALS and FTLD-MND | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,106,321 | September 29, 2021 | August 31, 2026 | DONNELLY, CHRISTOPHER JAMES | reporter.nih.gov |
| Inherited T cell defects: Diagnosis, Mechanisms and Treatments | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $9,040,281 | September 8, 2020 | August 31, 2025 | MARSON, ALEXANDER | reporter.nih.gov |
| Colon Cancer Family Registry Cohort | NIH | National Cancer Institute | 2021 to 2025 | $8,978,119 | May 1, 2013 | April 30, 2028 | JENKINS, MARK A | reporter.nih.gov |
| Development of Therapeutic Candidates for Biodefense, Infections and Emerging Infectious Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $8,743,439 | September 25, 2023 | June 24, 2024 | RAMSTEDT, URBAN | reporter.nih.gov |
| Kids First Data Resource Center (KFDRC): Harnessing Data-Driven Opportunities in the Present on behalf of the Future of Common Fund Data Ecosystem (CFDE) | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $8,664,754 | September 25, 2025 | March 24, 2027 | RESNICK, ADAM CAIN | reporter.nih.gov |
| Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. Coli Infection (HIKO STEC): A Multinational, Embedded, Cluster, Crossover, Randomized Trial | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,451,589 | September 17, 2021 | August 31, 2027 | FREEDMAN, STEPHEN BRADLEY | reporter.nih.gov |
| Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers | NIH | National Cancer Institute | 2021 to 2025 | $8,380,255 | September 15, 2020 | June 30, 2027 | KUSHI, LAWRENCE H | reporter.nih.gov |
| FEND for TB supplement to accelerate BLINK X development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $8,340,332 | June 4, 2020 | May 31, 2025 | ELLNER, JERROLD J. | reporter.nih.gov |
| San Francisco Bay Clinical Trials Unit (CTU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,314,128 | March 2, 2007 | November 30, 2027 | BUCHBINDER, SUSAN | reporter.nih.gov |
| ASYMMETRIC NEURODEGENERATION AND LANGUAGE IN PRIMARY PROGRESSIVE APHASIA | NIH | National Institute on Aging | 2022 to 2025 | $8,306,361 | June 15, 2022 | March 31, 2027 | MESULAM, MAREK-MARSEL M | reporter.nih.gov |
| Sex-based Differences in Glioma | NIH | National Cancer Institute | 2021 to 2025 | $8,258,328 | September 14, 2020 | December 31, 2026 | LATHIA, JUSTIN D. | reporter.nih.gov |
| The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,239,326 | January 15, 2008 | November 30, 2027 | GRINSZTEJN, BEATRIZ | reporter.nih.gov |
| The Physical Biology of Neurodegeneration in Sporadic Amyotrophic Lateral Sclerosis/Frontotemporal Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $8,227,499 | September 1, 2021 | August 31, 2027 | PHATNANI, HEMALI | reporter.nih.gov |
| A Multicenter Randomized Controlled Trial of Surveillance versus. Endoscopic Therapy for Barretts Esophagus with Low-grade Dysplasia: The SURVENT Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $8,184,774 | May 15, 2022 | April 30, 2027 | WANI, SACHIN | reporter.nih.gov |
| CCDI SUPPORT FOR NIH/NCI/DCCPS SURVEILLANCE RESEARCH PROGRAM | NIH | National Cancer Institute | 2021 to 2025 | $8,176,428 | August 16, 2021 | August 15, 2026 | reporter.nih.gov | |
| 1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $8,010,367 | September 16, 2020 | August 31, 2025 | BOECKH, MICHAEL J | reporter.nih.gov |
| Global Leukodystrophy Initiative Clinical Trials Network (GLIA- CTN) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $7,961,338 | September 30, 2019 | August 31, 2030 | VANDERVER, ADELINE LUCIE | reporter.nih.gov |
| Task C16: Production and Development of Schistosomiasis Research Reagents | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $7,933,000 | February 1, 2023 | January 31, 2026 | MENTINK-KANE, MARGARET | reporter.nih.gov |
| Communication Bridge: Optimizing an evidence-based intervention for individuals with primary progressive aphasia | NIH | National Institute on Aging | 2023 to 2025 | $7,878,167 | September 15, 2017 | August 31, 2028 | ROGALSKI, EMILY J | reporter.nih.gov |
| DartCF: The Dartmouth Cystic Fibrosis Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,832,026 | July 1, 2018 | August 31, 2030 | MADDEN, DEAN R | reporter.nih.gov |
| Integrating innate and adaptive pathways in vaccine responses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $7,762,589 | April 1, 2014 | March 31, 2024 | RAVETCH, JEFFREY VICTOR | reporter.nih.gov |
| Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2021 to 2025 | $7,757,977 | July 1, 2021 | June 30, 2027 | KAYED, RAKEZ | reporter.nih.gov |
| NCATS SCIENTIFIC AND TECHNOLOGY PROGRAM SUPPORT (STPS) | NIH | National Institute on Drug Abuse | 2025 | $7,700,000 | February 18, 2025 | September 27, 2025 | reporter.nih.gov | |
| Seattle Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $7,698,581 | February 1, 2007 | November 30, 2027 | MCELRATH, MARGARET JULIANA | reporter.nih.gov |
| CureGN | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,684,480 | September 16, 2013 | May 31, 2029 | MARIANI, LAURA H | reporter.nih.gov |
| Mechanisms Regulating Lung Injury and Early Lung Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $7,661,704 | July 1, 2023 | June 30, 2028 | SCHWARTZ, DAVID ALBERT | reporter.nih.gov |
| FEND for TB | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $7,632,771 | June 4, 2020 | May 31, 2026 | ELLNER, JERROLD J. | reporter.nih.gov |
| The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $7,511,308 | September 10, 2021 | August 31, 2027 | SAMET, JEFFREY H. | reporter.nih.gov |
| Advanced Development of Vaccines for Filoviruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $7,417,867 | July 21, 2020 | December 31, 2026 | ELDRIDGE, JOHN | reporter.nih.gov |
| Therapeutics targeting TDP-43 to treat Alzheimer's disease and related disorders | NIH | National Institute on Aging | 2021 to 2025 | $7,375,647 | July 1, 2021 | December 31, 2026 | REITZ, ALLEN BERNARD | reporter.nih.gov |
| "REAL Answers" (Registry Expansion Analyses to Learn) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $7,362,213 | August 20, 2023 | July 31, 2028 | GLASSBERG, JEFFREY AVINS | reporter.nih.gov |
| IGF::OT::IGFEMMES NEIS-V | NIH | Office of the Director, National Institutes of Health | 2021 | $7,315,897 | November 1, 2016 | October 31, 2021 | HAMMEL, KERI | reporter.nih.gov |
| Harmonist: A Scalable Toolkit for Standardizing and Coordinating Data Sharing Across International Research Networks | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $7,298,694 | May 25, 2016 | April 30, 2027 | DUDA, STEPHANY NORAH | reporter.nih.gov |
| TRANSPIRE: A Prospective Cohort Study of Lung Injury After Hematopoietic Stem Cell Transplant in Children. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,251,380 | September 1, 2021 | May 31, 2027 | DAVIES, STELLA MARGARET | reporter.nih.gov |
| Developmental Synaptopathies Associated with TSC, PTEN, SHANK3 and SynGAP1 Pathogenic Variants | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $7,185,368 | September 30, 2014 | July 31, 2030 | SAHIN, MUSTAFA | reporter.nih.gov |
| Coordinating center for the NCI small cell lung cancer research consortium | NIH | National Cancer Institute | 2021 to 2025 | $7,127,674 | June 24, 2022 | May 31, 2027 | RUDIN, CHARLES M. | reporter.nih.gov |
| Northwestern Cancer Prevention Consortium | NIH | National Cancer Institute | 2021 to 2025 | $7,062,222 | September 3, 2019 | July 31, 2031 | KHAN, SEEMA AHSAN | reporter.nih.gov |
| Molecules and Pathways at the Coccidioides Host-Pathogen Interface | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $7,052,234 | January 1, 2022 | December 31, 2026 | SIL, ANITA | reporter.nih.gov |
| iCAN PREVENT: MD Anderson International Cancer Prevention Clinical Trials Consortium | NIH | National Cancer Institute | 2021 to 2025 | $7,046,172 | August 15, 2019 | July 31, 2031 | VILAR SANCHEZ, EDUARDO | reporter.nih.gov |
| Sickle Cell Disease Cure Initiative (SCDC) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $7,000,926 | September 30, 2017 | June 30, 2026 | COLEMAN-COWGER, VICTORIA HOPE | reporter.nih.gov |
| 1/2 Sickel Cell Disease Treatment with Arginine Therapy (STArT Trial) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $6,920,555 | September 20, 2020 | August 31, 2026 | MORRIS, CLAUDIA R | reporter.nih.gov |
| Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $6,892,629 | September 15, 2004 | August 31, 2025 | FARRIS, A DARISE | reporter.nih.gov |
| Personalized prime editing as a platform for hepatic inborn errors of metabolism | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $6,886,793 | September 20, 2024 | August 31, 2028 | AHRENS-NICKLAS, REBECCA CLARE | reporter.nih.gov |
| Brittle Bone Disorders Consortium of the Rare Disease Clinical Research Network | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $6,852,525 | September 15, 2014 | August 31, 2030 | LEE, BRENDAN | reporter.nih.gov |
| The 10,000 Families Cohort: a new study to understand the environmental causes of cancer | NIH | National Cancer Institute | 2023 to 2025 | $6,827,634 | September 24, 2021 | August 31, 2028 | POYNTER, JENNY N. | reporter.nih.gov |
| Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $6,819,944 | September 15, 2019 | August 31, 2025 | HORNIK, CHRISTOPH | reporter.nih.gov |
| Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy. | NIH | National Cancer Institute | 2021 to 2025 | $6,769,276 | March 1, 2021 | August 31, 2027 | KAHALLEY, LISA SCHUM | reporter.nih.gov |
| A Severe Hemophilia A Intergenerational Cohort Research Program for the Study of Factor VIII Immunogenicity | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $6,768,642 | September 21, 2022 | August 31, 2025 | JOHNSEN, JILL MARIE | reporter.nih.gov |
| Subcutaneous Drug Development for Portal Hypertension Ascites | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,758,500 | September 22, 2014 | July 31, 2027 | CASTILLO, GERARDO M. | reporter.nih.gov |
| Emerging Infectious Diseases Research Center - East and Central Africa | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $6,734,930 | June 1, 2020 | June 5, 2025 | NJENGA, M KARIUKI | reporter.nih.gov |
| Emerging infections: surveillance, epidemiology and pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $6,690,286 | May 11, 2020 | June 5, 2025 | WANG, DAVID | reporter.nih.gov |
| Aurum Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,678,965 | December 1, 2020 | November 30, 2027 | CHURCHYARD, GAVIN JOHN | reporter.nih.gov |
| A Global Syphilis Vaccine Targeting Outer Membrane Proteins of Treponema pallidum. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $6,678,063 | May 1, 2019 | April 30, 2025 | RADOLF, JUSTIN D | reporter.nih.gov |
| West African Center for Emerging Infectious Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $6,658,566 | June 9, 2020 | June 5, 2025 | WEAVER, SCOTT C | reporter.nih.gov |
| B Cell Epitope Discovery and Mechanisms of Antibody Protection: Responses to Dengue 4, Powassan, Chikungunya, and Venezuelan Equine Encephalitis Viruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $6,634,396 | September 16, 2023 | September 15, 2024 | FREMONT, DAVED | reporter.nih.gov |
| Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $6,609,782 | September 30, 2014 | August 31, 2030 | BENATAR, MICHAEL | reporter.nih.gov |
| California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations | NIH | National Cancer Institute | 2021 to 2025 | $6,605,241 | September 12, 2019 | July 31, 2026 | PALEFSKY, JOEL MICHAEL | reporter.nih.gov |
| Facility and Building System Upgrades Support for the Howard T. Ricketts Biocontainment Laboratory | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $6,593,067 | September 16, 2021 | February 28, 2025 | ADAMS, ERIN JUNE | reporter.nih.gov |
| Precision Editing of Granulin Mutations that Cause Frontotemporal Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $6,580,415 | August 15, 2025 | July 31, 2029 | SONTHEIMER, ERIK J. | reporter.nih.gov |
| Washington University/Siteman Cancer Center Lead Academic Site | NIH | National Cancer Institute | 2021 to 2025 | $6,572,668 | March 5, 2019 | February 28, 2026 | BARTLETT, NANCY L | reporter.nih.gov |
| FMRP-mediated Regulation in Human Brain Development and Therapeutic Advancement | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $6,546,370 | September 25, 2020 | June 30, 2025 | JIN, PENG | reporter.nih.gov |
| Cavopulmonary Assist to Reverse the Fontan | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $6,543,627 | September 14, 2020 | August 31, 2025 | RODEFELD, MARK D | reporter.nih.gov |
| Translational medicine and mechanistic studies of brain neurophysiology in Fragile X Syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $6,538,717 | September 25, 2020 | June 30, 2025 | ERICKSON, CRAIG | reporter.nih.gov |
| Stellenbosch University Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,524,563 | April 15, 2007 | November 30, 2027 | HESSELING, ANNEKE CATHARINA | reporter.nih.gov |
| Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $6,498,374 | August 1, 2017 | July 31, 2027 | WARE, RUSSELL E | reporter.nih.gov |
| Novel therapy for alcoholic liver disease-associated hepatorenal syndrome | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $6,485,223 | September 25, 2021 | August 31, 2027 | SUBRAMANIAN, MANI | reporter.nih.gov |
| Coordinating Research on Emerging Arboviral Threats Encoing the Neotropics (CREATE-NEO) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $6,472,246 | June 1, 2020 | June 5, 2025 | VASILAKIS, NIKOS | reporter.nih.gov |
| Decoding mechanisms underlying metabolic dysregulation in obesity and digestive cancer risk | NIH | National Cancer Institute | 2022 to 2025 | $6,443,697 | September 20, 2022 | August 31, 2027 | TOBIAS, DEIRDRE KAY | reporter.nih.gov |
| METABOLIC ALDEHYDES AS IMMUNE EFFECTORS AGAINST TUBERCULOSIS | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,434,161 | September 11, 2025 | August 31, 2029 | DARWIN, KATERINA HERAN | reporter.nih.gov |
| University of Washington (UW) Sexually Transmitted Infections (STI) Cooperative Research Center (CRC) - Syphilis Vaccine to Protect against Local and Disseminated T. pallidum Infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $6,406,743 | August 1, 2019 | July 31, 2025 | WALD, ANNA | reporter.nih.gov |
| Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,398,428 | July 1, 2021 | June 30, 2027 | GENGENBACHER, MARTIN ALFONS | reporter.nih.gov |
| CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan | NIH | National Cancer Institute | 2023 to 2025 | $6,381,605 | September 22, 2021 | August 31, 2027 | FRIEDMAN, DEBRA L. | reporter.nih.gov |
| Biomarker Rich Clinical Trial of an Innovative Antibody Antagonist of TNFR2 in Non-Hodgkin Lymphoma Featuring Cutaneous T Cell Lymphoma (CTCL). | NIH | National Cancer Institute | 2021 to 2025 | $6,371,380 | September 1, 2021 | June 30, 2027 | BROOKS, DAVID G | reporter.nih.gov |
| Clinical-Translational Studies in Skin, Lung, and Vascular Complications in Systemic Sclerosis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $6,366,452 | September 20, 2022 | August 31, 2027 | LAFYATIS, ROBERT A. | reporter.nih.gov |
| American and Asian Centers for Arboviral Research and Enhanced Surveillance (A2CARES) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $6,361,142 | July 20, 2020 | May 31, 2025 | HARRIS, EVA | reporter.nih.gov |
| The LIMIting AAA with meTformin (LIMIT) Trial | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $6,355,802 | September 21, 2020 | June 30, 2027 | DALMAN, RONALD L | reporter.nih.gov |
| Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain | NIH | National Center for Complementary & Integrative Health | 2021 to 2024 | $6,352,490 | September 21, 2020 | August 31, 2025 | DOORENBOS, ARDITH Z | reporter.nih.gov |
| Pediatric Mendelian Genomics Research Center | NIH | National Human Genome Research Institute | 2023 to 2025 | $6,331,078 | June 1, 2021 | March 31, 2027 | VILAIN, ERIC J. | reporter.nih.gov |
| Biologically informed design of CD8+ T cell-dependent pre-erythrocytic stage malaria vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,330,175 | February 4, 2021 | January 31, 2026 | KAPPE, STEFAN HI | reporter.nih.gov |
| Enhancing immunity to malaria in young children with effective chemoprevention | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,263,495 | July 1, 2025 | June 30, 2027 | JAGANNATHAN, PRASANNA | reporter.nih.gov |
| NEWBORN SCREENING TRANSLATIONAL RESEARCH NETWORK (NBSTRN). | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $6,244,067 | September 26, 2018 | March 25, 2024 | BROWER, AMY | reporter.nih.gov |
| Translating genomic discoveries to improved outcomes for high risk acute leukemia | NIH | National Cancer Institute | 2021 to 2025 | $6,239,168 | January 19, 2017 | August 31, 2030 | MULLIGHAN, CHARLES G | reporter.nih.gov |
| Molecular Mechanisms of Pathogenesis in Huntington’s disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $6,238,150 | May 1, 2020 | April 30, 2028 | THOMPSON, LESLIE MICHELS | reporter.nih.gov |
| BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERSTASK ORDER TITLE: VACCINES AGAINST FUSOBACTERIUM FOR FAP-AND LYNCH SYNDROME-ASSOCIA | NIH | National Cancer Institute | 2022 to 2024 | $6,227,249 | June 15, 2022 | May 15, 2025 | CLAPPER, MARGIE L. | reporter.nih.gov |
| PET/MRI imaging of mitral valve prolapse | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $6,137,934 | August 25, 2023 | June 30, 2028 | TRIVIERI, MARIA GIOVANNA | reporter.nih.gov |
| S4 TO 108 NCATS GENE THERAPY VECTOR | NIH | Office of the Director, National Institutes of Health | 2021 to 2023 | $6,133,050 | September 30, 2021 | September 29, 2024 | KOROLEVA, ANNA | reporter.nih.gov |
| Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $6,050,572 | September 20, 2019 | March 31, 2027 | SPINO, CATHERINE A | reporter.nih.gov |
| La Spada Outstanding Investigator Award | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $6,002,158 | May 15, 2021 | April 30, 2029 | LA SPADA, ALBERT R | reporter.nih.gov |
| Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,977,497 | August 15, 2022 | July 31, 2027 | KANTER, JULIE | reporter.nih.gov |
| Partnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto Rico | NIH | National Cancer Institute | 2021 to 2025 | $5,948,066 | September 20, 2019 | July 31, 2026 | ELLSWORTH, GRANT B. | reporter.nih.gov |
| B-CELL EPITOPE DISCOVERY AND MECHANISMS OF ANTIBODY PROTECTION | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $5,936,710 | September 16, 2019 | August 31, 2025 | CROWE, JAMES E | reporter.nih.gov |
| Metabolic gatekeepers in B-cell malignancies | NIH | National Cancer Institute | 2021 to 2025 | $5,936,594 | April 1, 2016 | August 31, 2028 | MÜSCHEN, MARKUS | reporter.nih.gov |
| Expanding the breadth, magnitude, and durability of PfSPZ vaccines by creating multi-strain vaccines, designer hybrid and genetically altered parasite vaccines and use of a unique adjuvant. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,933,702 | April 8, 2021 | March 31, 2027 | SIM, B. KIM LEE | reporter.nih.gov |
| Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $5,901,662 | August 15, 2020 | May 31, 2026 | POLLAK, MARTIN R. | reporter.nih.gov |
| Hypertrophic Cardiomyopathy: Understanding the Heterogeneity of Disease Expression and Outcomes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $5,898,403 | September 1, 2021 | August 31, 2025 | HO, CAROLYN Y | reporter.nih.gov |
| Phase IA/IB Study of AAVrh.10hFXN Therapy to Treat the Cardiomyopathy of Friedreich's Ataxia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $5,884,638 | August 1, 2020 | August 31, 2025 | CRYSTAL, RONALD G | reporter.nih.gov |
| Novel Biologic Therapies for GVHD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,851,412 | February 1, 2010 | June 30, 2026 | KEAN, LESLIE S | reporter.nih.gov |
| Cardiovascular Development Data Resource Center (CDDRC) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $5,768,733 | August 20, 2020 | July 31, 2025 | YOST, H. JOSEPH | reporter.nih.gov |
| SWITCH Trial: Early Feasibility Study of Stentrode BCI for Augmentative Communication | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $5,728,624 | August 15, 2021 | July 31, 2027 | WEBER, DOUGLAS J | reporter.nih.gov |
| 1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $5,715,477 | September 23, 2019 | August 31, 2025 | LEVITT, JOSEPH ERIC | reporter.nih.gov |
| Histidine phosphorylation as a new target for cancer therapy | NIH | National Cancer Institute | 2021 to 2025 | $5,690,698 | September 18, 2019 | August 31, 2026 | HUNTER, TONY R. | reporter.nih.gov |
| Pediatric Solid Tumor Microenvironment Atlas | NIH | National Cancer Institute | 2024 to 2025 | $5,678,350 | September 1, 2024 | August 31, 2029 | ASGHARZADEH, SHAHAB | reporter.nih.gov |
| Identifying Multilevel Drivers of Differences in Ovarian Cancer Treatment and Survival: An Integrative Approach | NIH | National Cancer Institute | 2021 to 2025 | $5,668,317 | July 1, 2020 | June 30, 2027 | DOHERTY, JENNIFER ANNE | reporter.nih.gov |
| Computational models of naturally acquired immunity to falciparum malaria | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $5,666,873 | April 1, 2020 | March 31, 2026 | GREENHOUSE, BRYAN R | reporter.nih.gov |
| Improving Neonatal health Through Rapid malaria testing in Early Pregnancy with high-sensitivity Diagnostics (INTREPiD) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $5,664,388 | April 1, 2022 | March 31, 2027 | TAYLOR, STEVE MYER | reporter.nih.gov |
| CCC for NHLBI Prevention and Early Treatment of Acute Lung Injury PETAL Network | NIH | National Heart, Lung, and Blood Institute | 2021 | $5,617,232 | June 17, 2014 | October 31, 2023 | THOMPSON, BOYD TAYLOR | reporter.nih.gov |
| USIDNET: A resource for clinical immunologists | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $5,578,391 | August 24, 2022 | July 31, 2027 | SULLIVAN, KATHLEEN E | reporter.nih.gov |
| Mutographs differentiating the inheritance and temporal onset of multiple myeloma | NIH | National Cancer Institute | 2021 to 2025 | $5,575,548 | August 11, 2021 | July 31, 2026 | MORGAN, GARETH JOHN | reporter.nih.gov |
| The role of stem cells and the microenvironment in gastrointestinal cancers | NIH | National Cancer Institute | 2021 to 2025 | $5,569,272 | January 7, 2016 | August 31, 2030 | WANG, TIMOTHY CRAGIN | reporter.nih.gov |
| DON in Pediatric Cerebral Malaria: A Phase I / II Dose-Escalation Safety Study | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,567,850 | June 1, 2025 | May 31, 2027 | POSTELS, DOUGLAS | reporter.nih.gov |
| Myeloma multidimensional precancer atlas | NIH | National Cancer Institute | 2024 to 2025 | $5,566,942 | September 18, 2024 | August 31, 2029 | GHOBRIAL, IRENE M. | reporter.nih.gov |
| Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,559,114 | June 17, 2020 | January 31, 2027 | WALZL, GERHARD | reporter.nih.gov |
| Physical Activity in Pulmonary Arterial Hypertension (ACTiPH) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,556,139 | August 20, 2021 | May 31, 2027 | KAWUT, STEVEN M | reporter.nih.gov |
| Interplay of Myocardial Fibrosis and Cardiac TTR Amyloid in Age Related Cardiac Remodeling in MESA-Multi-Ethnic Study of Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,552,808 | April 1, 2022 | March 31, 2027 | LIMA, JOAO A C | reporter.nih.gov |
| NHLBI MAINTENANCE OF CANINE MODELS OF HUMAN BLEEDING DISORDERS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $5,542,798 | September 20, 2019 | September 19, 2024 | NICHOLS, TIMOTHY | reporter.nih.gov |
| Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders | NIH | National Institute of Mental Health | 2021 to 2023 | $5,538,172 | June 10, 2019 | March 31, 2026 | MARTIN, CHRISTA LESE | reporter.nih.gov |
| Inter-regional study of transmission, adaptation and pathogenesis of viruses with pandemic potential in Southeast Asia and West/Central Africa | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $5,526,401 | July 17, 2020 | June 5, 2025 | SAKUNTABHAI, ANAVAJ | reporter.nih.gov |
| Phase II clinical trial of transcranial direct current stimulation in the treatment of primary progressive aphasia | NIH | National Institute on Aging | 2022 to 2025 | $5,516,416 | September 30, 2022 | May 31, 2027 | HAMILTON, ROY H | reporter.nih.gov |
| DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,484,466 | August 21, 2020 | May 31, 2026 | NAHID, PAYAM | reporter.nih.gov |
| IND-Enabling Studies for Arenavirus Preclinical Candidate | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,459,651 | May 13, 2021 | January 31, 2027 | SOKOLOVA, NADEZDA V | reporter.nih.gov |
| An automated machine learning approach to language changes in Alzheimer’s disease and frontotemporal dementia across Latino and English-speaking populations | NIH | National Institute on Aging | 2023 to 2025 | $5,455,529 | August 15, 2023 | June 30, 2028 | GORNO TEMPINI, MARIA LUISA | reporter.nih.gov |
| Clinical Genetics and Screening for Pulmonary Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,442,199 | January 1, 2016 | November 30, 2026 | HUNNINGHAKE, GARY MATTHEW | reporter.nih.gov |
| Translational Control in Memory and Brain Disorders | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,426,946 | May 1, 2021 | April 30, 2029 | KLANN, ERIC | reporter.nih.gov |
| Vascular-immune mechanisms of cerebral amyloid angiopathy and Alzheimer's pathology | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $5,423,836 | September 19, 2024 | August 31, 2027 | YANG, ANDREW CHRIS | reporter.nih.gov |
| NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care | NIH | National Cancer Institute | 2021 to 2025 | $5,422,908 | March 5, 2019 | February 28, 2026 | BURSTEIN, HAROLD JOHN | reporter.nih.gov |
| Structure-Function Analysis of Mxra8 Interaction with Alphaviruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,414,348 | June 1, 2019 | July 31, 2029 | DIAMOND, MICHAEL S | reporter.nih.gov |
| Developing computational models to predict the immune response to B. pertussis booster vaccination | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $5,401,756 | March 10, 2020 | February 28, 2025 | PETERS, BJOERN | reporter.nih.gov |
| The Columbia PCC for CureGN: the Cure Glomerulonephropathy network | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $5,398,076 | September 16, 2013 | May 31, 2029 | BOMBACK, ANDREW STEPHEN | reporter.nih.gov |
| A National Center for Digital Health Informatics Innovation | NIH | National Center for Advancing Translational Sciences | 2021 | $5,392,642 | September 25, 2021 | June 30, 2023 | HAENDEL, MELISSA A | reporter.nih.gov |
| New mechanisms and technologies for understanding post-transcriptional gene regulation in neurons | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,391,456 | June 1, 2019 | May 31, 2027 | JAFFREY, SAMIE R | reporter.nih.gov |
| Center for Advanced Multi-Omic Characterization of Cancer | NIH | National Cancer Institute | 2022 to 2025 | $5,390,170 | June 1, 2022 | May 31, 2027 | LIU, TAO | reporter.nih.gov |
| 2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Center | NIH | National Cancer Institute | 2021 to 2025 | $5,355,395 | September 17, 2018 | August 31, 2028 | WILKIE, DIANA J | reporter.nih.gov |
| Investigating the Benefits of Remotely-supervised Neuromodulation in Primary Progressive Aphasia | NIH | National Institute on Aging | 2025 | $5,343,452 | September 15, 2025 | August 31, 2029 | HENRY, MAYA | reporter.nih.gov |
| Chicago Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,330,849 | February 1, 2007 | November 30, 2027 | ACHENBACH, CHAD J | reporter.nih.gov |
| Translating Pathomechanisms into Treatment for Spinal Muscular Atrophies | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,290,574 | May 5, 2021 | April 30, 2029 | SUMNER, CHARLOTTE JANE | reporter.nih.gov |
| A Human iPSC-based Cell Therapy for Canavan Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $5,276,950 | June 15, 2021 | May 31, 2027 | SHI, YANHONG | reporter.nih.gov |
| Understanding the role of tumor microenvironment in low grade glioma progression to malignancy | NIH | National Cancer Institute | 2024 to 2025 | $5,275,940 | September 1, 2024 | August 31, 2029 | CAI, LONG | reporter.nih.gov |
| Endoscopic versus Shunt Treatment of Hydrocephalus in Infants | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $5,269,023 | September 15, 2019 | August 31, 2027 | KESTLE, JOHN | reporter.nih.gov |
| Cell plasticity in the origin of gastric carcinogenesis | NIH | National Cancer Institute | 2022 to 2025 | $5,262,457 | September 1, 2025 | August 31, 2027 | CHOI, EUNYOUNG | reporter.nih.gov |
| New Mechanistic Insights & Therapeutic Applications of Megakaryocytes/Platelets | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,258,818 | May 1, 2020 | April 30, 2027 | PONCZ, MORTIMER | reporter.nih.gov |
| Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery | NIH | National Cancer Institute | 2021 to 2025 | $5,246,301 | August 1, 2015 | July 31, 2028 | MEYERSON, MATTHEW L. | reporter.nih.gov |
| Supplement to G20AI67347 to complete critical upgrades to the Rutgers RBL | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $5,241,770 | August 22, 2022 | February 29, 2024 | ALLAND, DAVID | reporter.nih.gov |
| System Wide Operations for Rare Disorders (SWORD) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $5,227,397 | September 30, 2009 | June 30, 2025 | KIM, HELEN | reporter.nih.gov |
| Advancing RNA Therapeutics for Huntington’s Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $5,226,511 | February 1, 2020 | January 31, 2026 | ARONIN, NEIL | reporter.nih.gov |
| Novel therapeutic development for small cell lung cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,214,420 | August 10, 2021 | July 31, 2028 | RUDIN, CHARLES M. | reporter.nih.gov |
| CureGN-Penn PCC | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $5,209,008 | September 16, 2013 | May 31, 2029 | HOLZMAN, LAWRENCE B. | reporter.nih.gov |
| Advancement of a poxvirus antiviral | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,192,454 | March 12, 2020 | August 31, 2029 | CONNOR, JOHN H | reporter.nih.gov |
| The TGFÃÂÃÂÃÂò Signaling Pathway in Development and Cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,182,391 | September 1, 2020 | August 31, 2027 | MASSAGUE, JOAN | reporter.nih.gov |
| CureSC Manufacturing Resource Platform | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $5,179,238 | September 27, 2019 | September 30, 2026 | CARDOSO, ANGELO A. | reporter.nih.gov |
| Digital Health Technologies for Monitoring Motor Function in Progressive Supranuclear Palsy and Dementia with Lewy Bodies | NIH | National Institute on Aging | 2025 | $5,174,076 | September 1, 2025 | August 31, 2029 | VAZIRI, ASHKAN | reporter.nih.gov |
| Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations | NIH | National Cancer Institute | 2021 to 2025 | $5,173,906 | August 8, 2019 | July 31, 2026 | DECAPRIO, JAMES A. | reporter.nih.gov |
| Reading mitochondrial apoptotic signaling to identify active cancer therapeutics | NIH | National Cancer Institute | 2021 to 2025 | $5,159,959 | August 1, 2019 | September 29, 2025 | LETAI, ANTHONY G | reporter.nih.gov |
| Center for Gastric Pre-Cancer Atlas of Multidimensional Evolution in 3D (GAME3D) | NIH | National Cancer Institute | 2024 to 2025 | $5,158,661 | September 1, 2024 | August 31, 2029 | WANG, LINGHUA | reporter.nih.gov |
| MaineHealth Cancer Care Network (MHCCN) and NCORP Activities across the Lifespan | NIH | National Cancer Institute | 2021 to 2025 | $5,149,103 | August 13, 2019 | July 31, 2026 | REMICK, SCOT C | reporter.nih.gov |
| Decrypting Variants of Uncertain Significance in Long-QT Syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $5,148,685 | August 1, 2014 | July 31, 2026 | GEORGE, ALFRED L. | reporter.nih.gov |
| Center for Human Lymphoma Spatiotemporal Atlas (HuLymSTA) | NIH | National Cancer Institute | 2024 to 2025 | $5,130,804 | September 1, 2024 | August 31, 2029 | FAN, RONG | reporter.nih.gov |
| Fecal Microbiota Transplantation and Fiber for the Treatment of Graft-versus-host Disease After Hematopoietic Cell Transplantation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $5,128,451 | September 1, 2023 | June 30, 2027 | FREDRICKS, DAVID NEAL | reporter.nih.gov |
| Novel Strategies to Improve Blood Transfusion Practice | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $5,119,758 | August 15, 2022 | July 31, 2027 | LUO, HONGBO R | reporter.nih.gov |
| Targeting Dysregulated RNA Splicing in Neurodegenerative Diseases | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $5,093,143 | September 1, 2023 | August 31, 2028 | LAGIER-TOURENNE, CLOTILDE | reporter.nih.gov |
| Towards targeting the lymphoma microenvironment | NIH | National Cancer Institute | 2021 to 2025 | $5,082,235 | September 1, 2020 | August 31, 2027 | WENDEL, HANS-GUIDO | reporter.nih.gov |
| Survivorship and Access to care for Latinos to Understand and Address health outcome Differences (SALUD) | NIH | National Cancer Institute | 2023 to 2025 | $5,079,158 | May 10, 2021 | April 30, 2027 | GRAMATGES, MARIA MONICA | reporter.nih.gov |
| Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $5,061,587 | May 10, 2021 | April 30, 2027 | TRAPNELL, BRUCE C | reporter.nih.gov |
| BioRepository for INvestigation of Diseases of the Lung (BRINDL) - Phase III | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,051,640 | August 23, 2019 | August 31, 2029 | PRYHUBER, GLORIA S | reporter.nih.gov |
| An atlas of pancreatic tumorigenesis in the context of altered DNA repair occurring in high-risk individuals | NIH | National Cancer Institute | 2024 to 2025 | $5,050,023 | September 1, 2024 | August 31, 2029 | SEARS, ROSALIE C | reporter.nih.gov |
| Focal mass drug administration (fMDA) to reduce Plasmodium vivax transmission, a pragmatic cluster randomized controlled trial in Peru | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $5,036,878 | June 1, 2025 | May 31, 2027 | HSIANG, MICHELLE SANG | reporter.nih.gov |
| Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infection | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $5,036,160 | September 1, 2022 | August 31, 2027 | CHANG, AILEEN | reporter.nih.gov |
| Identifying the mechanisms of leukemia progression | NIH | National Cancer Institute | 2021 to 2025 | $5,032,279 | September 22, 2021 | August 31, 2028 | CRISPINO, JOHN D | reporter.nih.gov |
| 1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,023,972 | April 1, 2022 | March 31, 2029 | SHAW, BRONWEN | reporter.nih.gov |
| Pancreatic Cancer Detection Consortium | NIH | National Cancer Institute | 2021 to 2025 | $5,023,372 | May 1, 2017 | August 31, 2027 | HOLLINGSWORTH, MICHAEL A. | reporter.nih.gov |
| A national Asian American cohort for assessing multi-level determinants in cancer etiology: the ASPIRE Cohort | NIH | National Cancer Institute | 2024 to 2025 | $5,021,641 | July 8, 2024 | June 30, 2029 | GOMEZ, SCARLETT L | reporter.nih.gov |
| Quanitifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $5,011,286 | April 1, 2020 | March 31, 2026 | VAZQUEZ PROKOPEC, GONZALO MARTIN | reporter.nih.gov |
| DEVELOPMENT OF PAN-FILOVIRUS THERAPEUTICS | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $5,008,204 | November 1, 2022 | March 1, 2027 | BOWLIN, TERRY | reporter.nih.gov |
| Homology-directed repair: BRCA2 and RAD51 paralogs | NIH | National Cancer Institute | 2021 to 2025 | $5,007,139 | August 1, 2020 | July 31, 2027 | JASIN, MARIA | reporter.nih.gov |
| Developing a kit-based research use only (RUO) translocation assay for deployment as a lab developed test (LDT) toward changing outcomes for patients with driver-negative tumors | NIH | National Cancer Institute | 2021 to 2024 | $4,982,588 | May 1, 2020 | April 30, 2025 | SELVARAJ, SIDDARTH | reporter.nih.gov |
| The role and mechanism of alternative RNA splice variants and gene fusions as drivers of cancer | NIH | National Cancer Institute | 2021 to 2025 | $4,965,167 | September 21, 2021 | August 31, 2028 | HOLLAND, ERIC C. | reporter.nih.gov |
| The North American Mitochondrial Disease Consortium (NAMDC) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $4,960,512 | September 30, 2011 | March 12, 2025 | HIRANO, MICHIO | reporter.nih.gov |
| Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis | NIH | National Cancer Institute | 2021 to 2025 | $4,951,939 | August 14, 2015 | July 31, 2029 | ATTARDI, LAURA D | reporter.nih.gov |
| Leveraging Natural Phenotypic Variations of Heterogenous ALS Populations-in-a-Dish to Enable Scalable Drug Discovery | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $4,949,698 | September 18, 2022 | August 31, 2027 | ICHIDA, JUSTIN KAWIKA | reporter.nih.gov |
| Gastroesophageal junction stem cells as the origin of Barretts esophagus and cancer | NIH | National Cancer Institute | 2022 to 2025 | $4,948,268 | September 1, 2025 | August 31, 2027 | WANG, TIMOTHY CRAGIN | reporter.nih.gov |
| Bacteriophage-based approach for managing Shigella infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,946,719 | May 5, 2020 | April 30, 2026 | SULAKVELIDZE, ALEXANDER | reporter.nih.gov |
| Puerto Rico NCI Community Oncology Research Program (Puerto Rico NCORP) | NIH | National Cancer Institute | 2021 to 2025 | $4,943,161 | August 22, 2014 | July 31, 2026 | SANTOS-REYES, LUIS JAVIER | reporter.nih.gov |
| Reprogramming the Tumor-Immune Interface in Oral Cancer | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $4,940,407 | September 8, 2020 | June 30, 2028 | SUNWOO, JOHN B | reporter.nih.gov |
| Targeting the MYC Pathway for the Treatment of Cancer | NIH | National Cancer Institute | 2021 to 2025 | $4,931,456 | September 8, 2020 | August 31, 2027 | FELSHER, DEAN W | reporter.nih.gov |
| IGF::OT::IGF THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY, DATA COORDINATING CENTER (DCC), TASK ORDER 03, SEPTEMBER 1, 2016-FEBRUARY 28, 2018 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,930,056 | September 1, 2016 | December 31, 2025 | STABLIN, DON | reporter.nih.gov |
| Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $4,927,507 | May 5, 2010 | August 31, 2025 | VANDENBORNE, KRISTA H | reporter.nih.gov |
| Preclinical development of a vaccine for Nipah virus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,912,518 | March 11, 2021 | February 28, 2027 | GEISBERT, THOMAS WILLIAM | reporter.nih.gov |
| The St. Jude Lifetime Cohort | NIH | National Cancer Institute | 2021 to 2024 | $4,907,509 | July 9, 2015 | June 30, 2025 | HUDSON, MELISSA M | reporter.nih.gov |
| Living in the post-Zika world: Impact of interactions between dengue and Zika viruses on diagnostics, antibody dynamics, and correlates of disease risk | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,905,886 | July 13, 2021 | April 30, 2027 | HARRIS, EVA | reporter.nih.gov |
| Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $4,889,710 | June 7, 2024 | June 1, 2026 | BRUYETTE, DAVID | reporter.nih.gov |
| The von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer: Insights into Oxygen Sensing and Treating Cancers Caused by Undruggable Mutations | NIH | National Cancer Institute | 2021 to 2025 | $4,888,860 | September 1, 2016 | August 31, 2030 | KAELIN, WILLIAM G. | reporter.nih.gov |
| Large Scale T Cell Epitope Discovery:Global identification of epitopes derived from Zika (ZIKV), Chikungunya (CHIKV) viruses following natural infection and vaccination | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $4,881,220 | September 30, 2019 | September 29, 2024 | MITCHELL, MAYA | reporter.nih.gov |
| Development of Radiation/Nuclear Medical Countermeasures (MCMs) and Biodosimetry Devices | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $4,879,349 | July 1, 2023 | June 30, 2026 | NGUYEN, THERESA | reporter.nih.gov |
| Targeted DOK7 gene therapy for Congenital Myasthenic Syndromes | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $4,856,116 | September 15, 2021 | August 31, 2026 | SEPULVEDA, PATRICIO | reporter.nih.gov |
| Trial of Exercise and Lifestyle (TEAL) in Women with Ovarian Cancer | NIH | National Cancer Institute | 2022 to 2025 | $4,851,495 | May 23, 2022 | April 30, 2027 | IRWIN, MELINDA L | reporter.nih.gov |
| Investigating the heterogeneity and coordination of hematopoietic stem cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,840,269 | August 1, 2020 | July 31, 2027 | LU, RONG | reporter.nih.gov |
| Web-based Automated Imaging Differentiation of Parkinsonism | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,837,150 | April 1, 2021 | March 31, 2027 | VAILLANCOURT, DAVID E | reporter.nih.gov |
| Accelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,835,728 | December 1, 2020 | November 30, 2026 | ADAMS, JOHN H | reporter.nih.gov |
| Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,831,256 | December 1, 2021 | November 30, 2026 | RENGARAJAN, JYOTHI | reporter.nih.gov |
| Predicting Pancreatic Ductal Adenocarcinoma (PDAC) Through Artificial Intelligence Analysis of Pre-Diagnostic CT Images | NIH | National Cancer Institute | 2021 to 2025 | $4,827,743 | September 1, 2021 | August 31, 2026 | LI, DEBIAO | reporter.nih.gov |
| Mechanisms of Cell Regulation and Manipulation by the Ubiquitin System | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,827,601 | June 1, 2020 | May 31, 2030 | HOCHSTRASSER, MARK W | reporter.nih.gov |
| Endosomal mechanisms signaling oral cancer pain | NIH | National Institute of Dental & Craniofacial Research | 2023 | $4,820,611 | September 19, 2023 | August 31, 2026 | SCHMIDT, BRIAN L | reporter.nih.gov |
| From pathogenesis to new therapeutic targets in diffuse large B cell lymphoma | NIH | National Cancer Institute | 2021 to 2025 | $4,812,450 | September 12, 2023 | July 31, 2030 | DALLA-FAVERA, RICCARDO | reporter.nih.gov |
| Optimal chemopreventive regimens to prevent malaria and improve birth outcomes in Uganda | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,809,096 | April 15, 2020 | March 31, 2026 | DORSEY, MATTHEW G | reporter.nih.gov |
| Novel Stem Cell Immunotherapy for MDR-Tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,800,190 | June 4, 2021 | May 31, 2026 | JAGANNATH, CHINNASWAMY | reporter.nih.gov |
| Genomic medicine and gene function implementation for an underserved population | NIH | National Human Genome Research Institute | 2021 to 2025 | $4,796,292 | July 13, 2021 | April 30, 2027 | BELLEN, HUGO J | reporter.nih.gov |
| Unmasking the roles of viral glycoproteins in oral transmission of KSHV | NIH | National Cancer Institute | 2021 to 2025 | $4,786,354 | September 1, 2021 | August 31, 2026 | OGEMBO, JAVIER GORDON | reporter.nih.gov |
| A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $4,780,411 | April 5, 2019 | March 31, 2026 | WILCOX, DAVID ALLEN | reporter.nih.gov |
| Sickle Africa Data Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,779,335 | April 1, 2017 | April 30, 2027 | WONKAM, AMBROISE | reporter.nih.gov |
| Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II) | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $4,760,584 | September 23, 2025 | August 31, 2030 | NAHID, PAYAM | reporter.nih.gov |
| Post genome wide association studies in testicular germ cell tumors | NIH | National Cancer Institute | 2021 to 2024 | $4,743,103 | September 21, 2012 | August 31, 2025 | NATHANSON, KATHERINE L. | reporter.nih.gov |
| Mechanistic studies of chromatin modification in transcription regulation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,727,113 | February 14, 2019 | April 30, 2029 | WOLBERGER, CYNTHIA | reporter.nih.gov |
| Investigating molecular and cellular mechanisms of SCLC development to identify novel therapeutic strategies | NIH | National Cancer Institute | 2021 to 2025 | $4,726,654 | September 9, 2019 | August 31, 2026 | SAGE, JULIEN | reporter.nih.gov |
| Metabolic Influences on Complex Tumor Neighborhoods | NIH | National Cancer Institute | 2021 to 2025 | $4,722,150 | August 1, 2017 | July 31, 2030 | SIMON, M. CELESTE | reporter.nih.gov |
| Development of Non-Human Primate Models to Assess Immunological Mechanisms and Antigenic Targets of Protective Sporozoite (SPZ) Vaccines and Establish Superior Efficacy of Next Generation SPZ vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,717,265 | April 1, 2021 | March 31, 2027 | HOFFMAN, STEPHEN LEV | reporter.nih.gov |
| PRESCIENT: A phase IIc, open-label, randomized controlled trial of ultra-short course bedaquiline, clofazimine, pyrazinamide and delamanid versus standard therapy for drug-susceptible tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,716,636 | May 1, 2025 | April 30, 2027 | KOENIG, SERENA PATRICIA | reporter.nih.gov |
| Severe Chronic Neutropenia International Registry | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,709,229 | August 1, 2025 | July 31, 2027 | SHIMAMURA, AKIKO | reporter.nih.gov |
| Primary Progressive Aphasia: Cognition, Anatomy and Progression | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $4,705,247 | July 15, 2004 | August 31, 2025 | GORNO TEMPINI, MARIA LUISA | reporter.nih.gov |
| DEVELOPMENT OF SAPONIN DMLT ADJUVANT (SDA) | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $4,695,387 | September 30, 2023 | September 29, 2026 | NORTON, ELIZABETH | reporter.nih.gov |
| Multi-site validation of biomarkers and core clinical outcome measures for clinical trial readiness in CDKL5 Deficiency Disorder - Supplement | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,693,682 | February 15, 2021 | January 31, 2027 | BENKE, TIMOTHY A | reporter.nih.gov |
| Human metabolic variation as a window into cancer initiation and progression | NIH | National Cancer Institute | 2021 to 2025 | $4,687,860 | September 4, 2017 | August 31, 2030 | DEBERARDINIS, RALPH J | reporter.nih.gov |
| Mechanisms of innate immune dysfunction in SIV/malaria co-infection in pregnancy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $4,672,308 | September 24, 2021 | July 31, 2026 | MANUZAK, JENNIFER | reporter.nih.gov |
| PANDA-MSD: Predictive Analytics via Networked Distributed Algorithms for Multi-System Diseases | NIH | National Center for Advancing Translational Sciences | 2022 to 2025 | $4,670,835 | August 5, 2022 | May 31, 2027 | CHEN, YONG | reporter.nih.gov |
| Development of Innovative Resources to Advance MDS Research | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $4,661,966 | September 15, 2023 | July 31, 2028 | BLEAKLEY, MARIE | reporter.nih.gov |
| Live-cell Activity Architecture in Cancer | NIH | National Cancer Institute | 2021 to 2025 | $4,655,641 | August 1, 2015 | July 31, 2029 | ZHANG, JIN | reporter.nih.gov |
| Clinical Trial Site Monitoring for PHOENIx MDR-TB | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,653,435 | April 15, 2025 | December 14, 2025 | SMITH, KIMBERLY | reporter.nih.gov |
| DYNAMICS AND EVOLUTION OF IMMUNE RESPONSES TO INFLUENZA VIRUSES | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,647,135 | June 29, 2020 | May 31, 2026 | ANTIA, RUSTOM NOSHIR | reporter.nih.gov |
| Investigation of the Cortical Communication (CORTICOM) System | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,646,011 | September 15, 2020 | December 31, 2025 | CRONE, NATHAN E | reporter.nih.gov |
| Nephrotic Syndrome Rare Disease Clinical Research Network III | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $4,641,008 | September 8, 2009 | June 30, 2025 | KRETZLER, MATTHIAS | reporter.nih.gov |
| Mutations of Chromatin and its Modifying Machineries in Malignancies | NIH | National Cancer Institute | 2021 to 2025 | $4,635,274 | August 13, 2015 | August 31, 2029 | SHILATIFARD, ALI | reporter.nih.gov |
| Toward efficient performance for deep learning on medical imaging | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,624,228 | April 1, 2020 | March 31, 2030 | ARNAOUT, RIMA | reporter.nih.gov |
| Decoding and Targeting the PI3K-mTOR Signaling Network in Cancer | NIH | National Cancer Institute | 2021 to 2025 | $4,612,435 | August 1, 2022 | July 31, 2029 | MANNING, BRENDAN D. | reporter.nih.gov |
| MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $4,608,548 | January 1, 2023 | December 31, 2023 | COFFIN, JEANETTE | reporter.nih.gov |
| Proteogenomic characterization of early and late resistance mechanisms in acute myeloid leukemia | NIH | National Cancer Institute | 2022 to 2025 | $4,603,890 | June 15, 2022 | May 31, 2027 | TYNER, JEFFREY WALLACE | reporter.nih.gov |
| A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform | NIH | National Center for Advancing Translational Sciences | 2021 to 2024 | $4,598,428 | July 1, 2021 | April 30, 2026 | HINGTGEN, SHAWN | reporter.nih.gov |
| Chemical Approaches to Modulate PAX3-FOXO1 in Fusion-Positive Alveolar Rhabdomyosarcoma | NIH | National Cancer Institute | 2024 to 2025 | $4,597,865 | September 6, 2024 | August 31, 2029 | KOEHLER, ANGELA NICOLE | reporter.nih.gov |
| Molecular and Cellular Regulation of Pre-Leukemic Stem Cells and their Therapeutic Targeting | NIH | National Cancer Institute | 2021 to 2025 | $4,594,192 | September 1, 2021 | August 31, 2028 | STEIDL, ULRICH | reporter.nih.gov |
| Molecular Pathogenesis of Acute Myeloid Leukemia | NIH | National Cancer Institute | 2021 to 2025 | $4,591,274 | August 13, 2015 | June 30, 2029 | LEY, TIMOTHY J. | reporter.nih.gov |
| Tissue factor-dependent coagulation in thrombosis and immune responses | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,577,076 | February 1, 2021 | January 31, 2028 | MACKMAN, NIGEL | reporter.nih.gov |
| Mechanisms underlying gastric intestinal metaplasia and carcinogenesis | NIH | National Cancer Institute | 2022 to 2025 | $4,560,310 | September 20, 2022 | August 31, 2027 | RUSTGI, ANIL K | reporter.nih.gov |
| Targeting transcriptional addiction in fusion-driven sarcoma | NIH | National Cancer Institute | 2024 to 2025 | $4,553,009 | July 8, 2024 | June 30, 2029 | MCFADDEN, DAVID GLENN | reporter.nih.gov |
| Therapeutic Targeting of Human AML Stem Cells | NIH | National Cancer Institute | 2021 to 2025 | $4,546,001 | September 8, 2020 | August 31, 2027 | JORDAN, CRAIG T. | reporter.nih.gov |
| Coordinate Regulation of Virulence in Vibrio Cholerae | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,541,366 | July 1, 1981 | March 31, 2029 | MEKALANOS, JOHN JOSEPH | reporter.nih.gov |
| Long-term health and socioeconomic impact of interventions targeting low-density malaria infection (LMI) among children in Tanzaniav | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,537,676 | April 15, 2022 | March 31, 2027 | HSIANG, MICHELLE SANG | reporter.nih.gov |
| Ovarian Cancer Survival in African-American Women | NIH | National Cancer Institute | 2021 to 2024 | $4,527,423 | July 1, 2020 | June 30, 2026 | SCHILDKRAUT, JOELLEN M. | reporter.nih.gov |
| T cell recognition of the MR1 presented microbial metabolome | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $4,523,152 | July 10, 2019 | June 30, 2025 | ADAMS, ERIN JUNE | reporter.nih.gov |
| CUREGN 3.0 - Pediatric Nephrology Consortium - PCC | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,521,564 | September 16, 2013 | May 31, 2029 | SMOYER, WILLIAM E | reporter.nih.gov |
| Pathological Mechanisms of Human Cerebellar Malformations | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,519,501 | September 1, 2016 | June 30, 2028 | MILLEN, KATHLEEN JOYCE | reporter.nih.gov |
| Texas Pediatric NCORP | NIH | National Cancer Institute | 2021 to 2025 | $4,510,206 | August 1, 2014 | July 31, 2026 | LANGEVIN, ANNE-MARIE R. | reporter.nih.gov |
| Determinants of the racial/ethnic disparity in MGUS risk: An epidemiologic study in 4 cohorts | NIH | National Cancer Institute | 2021 to 2025 | $4,479,852 | September 20, 2021 | August 31, 2026 | COZEN, WENDY | reporter.nih.gov |
| Impact of tuberculosis on the development and function of the immune system in SIV-infected infants | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $4,476,086 | April 1, 2019 | March 31, 2025 | WANG, XIAOLEI | reporter.nih.gov |
| Understanding Risk of Zoonotic Virus Emergence in EID Hotspots of Southeast Asia | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $4,474,707 | June 17, 2020 | May 15, 2024 | DASZAK, PETER | reporter.nih.gov |
| Early Pathogenesis of Cystic Fibrosis Related Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $4,452,977 | April 30, 2021 | March 31, 2024 | ENGELHARDT, JOHN F | reporter.nih.gov |
| The Duke FUNCTION Center: Pioneering the comprehensive identification of combinatorial noncoding causes of disease | NIH | National Human Genome Research Institute | 2023 to 2024 | $4,449,876 | September 24, 2020 | June 30, 2025 | REDDY, TIMOTHY E | reporter.nih.gov |
| A systems analysis of drug tolerance in Mycobacterium tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,414,678 | December 1, 2016 | June 30, 2027 | BALIGA, NITIN S | reporter.nih.gov |
| Sodium and Calcium Channels: Structure, Function, Neuroplasticity, and Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $4,413,116 | May 1, 2019 | April 30, 2025 | SCOTT, JOHN D | reporter.nih.gov |
| U24-Uncovering the Shared Genetic Origins of Childhood Cancer and Structural Birth Defects Through Enhanced Data Integration and Analysis with the CFDE Data Distillery Knowledge Graph. | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $4,408,884 | September 19, 2024 | August 31, 2027 | TAYLOR, DEANNE MARIE | reporter.nih.gov |
| Vaccine and Treatment Evaluation Units: Wolbachia-Infected Aedes aegypti Mosquitos in Reducing Arboviral Infection Brazil | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,402,306 | February 4, 2020 | November 30, 2027 | ROUPHAEL, NADINE | reporter.nih.gov |
| Pediatric Early Phase Clinical Trials Network (PEP-CTN) Transfer Application | NIH | National Cancer Institute | 2025 | $4,394,441 | August 1, 2025 | July 31, 2029 | FOX, ELIZABETH | reporter.nih.gov |
| Single-neuron population dynamics in human speech motor cortex for a speech prosthesis | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $4,390,591 | August 2, 2021 | July 31, 2027 | HENDERSON, JAIMIE M | reporter.nih.gov |
| ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC) | NIH | National Cancer Institute | 2021 to 2025 | $4,374,283 | March 1, 2025 | February 28, 2026 | LEVINE, ROSS L | reporter.nih.gov |
| Genetic Susceptibility and Biomarkers of Platinum-related Toxicities | NIH | National Cancer Institute | 2021 to 2025 | $4,370,186 | September 25, 2012 | June 30, 2027 | TRAVIS, LOIS B. | reporter.nih.gov |
| Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $4,359,590 | December 1, 2016 | November 30, 2024 | GITLER, AARON D. | reporter.nih.gov |
| Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and Risk | NIH | National Cancer Institute | 2021 to 2025 | $4,355,861 | January 13, 2021 | December 31, 2026 | GOODE, ELLEN L. | reporter.nih.gov |
| 1/2 PROSpect: Prone and Oscillation Pediatric Clinical Trial (CCC) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $4,351,796 | June 15, 2018 | July 31, 2025 | CURLEY, MARTHA AQ | reporter.nih.gov |
| High performance wearable body odor sensor arrays for disease detection and monitoring | NIH | National Center for Advancing Translational Sciences | 2022 to 2025 | $4,350,648 | August 10, 2022 | May 31, 2027 | FAN, XUDONG | reporter.nih.gov |
| SCAN-MP (Screening for Cardiac Amyloidosiswith Nuclear imaging in Minority Populations) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $4,328,776 | May 1, 2019 | February 28, 2025 | MAURER, MATHEW S | reporter.nih.gov |
| Alleviation of ER stress as a translational strategy to curb ocular viral infections | NIH | National Eye Institute | 2022 to 2025 | $4,325,995 | March 1, 2022 | December 31, 2026 | SHUKLA, DEEPAK | reporter.nih.gov |
| Large Scale T Cell Epitope Discovery | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,323,930 | September 29, 2019 | September 29, 2025 | GAGE, KASIA | reporter.nih.gov |
| Molecular and Translational Studies in Hematologic Disorders | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $4,297,096 | March 15, 2019 | February 28, 2025 | LOPEZ, JOSE ARON | reporter.nih.gov |
| Impact of Infection and Inflammation on Primitive Hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,290,831 | July 1, 2021 | June 30, 2028 | KING, KATHERINE YUDEH | reporter.nih.gov |
| Preclinical Pulmonary Fibrosis, an opportune rare disease cohort | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,290,758 | August 20, 2020 | July 31, 2026 | SCHWARTZ, DAVID ALBERT | reporter.nih.gov |
| Pediatric Oncology In Vivo Testing Program Coordinating Center | NIH | National Cancer Institute | 2021 to 2025 | $4,288,627 | August 25, 2021 | June 30, 2026 | BULT, CAROL J | reporter.nih.gov |
| KSHV Subunit Vaccine Candidates to Elicit Potent Humoral Immune Reponses against KSHV Infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,284,115 | March 22, 2021 | February 28, 2027 | OGEMBO, JAVIER GORDON | reporter.nih.gov |
| CureGN-3: UNCPCC | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,280,738 | September 16, 2013 | May 31, 2029 | FALK, RONALD J | reporter.nih.gov |
| Porphyrias Consortium | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $4,280,404 | September 30, 2009 | June 30, 2025 | DESNICK, ROBERT J | reporter.nih.gov |
| The Role of the MBD2-NuRD Complex in Gamma-Globin Gene Silencing | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,278,408 | August 1, 2018 | August 31, 2029 | GINDER, GORDON D | reporter.nih.gov |
| The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors | NIH | National Cancer Institute | 2021 to 2025 | $4,277,018 | September 1, 2021 | August 31, 2027 | SIGEL, KEITH MAGNUS | reporter.nih.gov |
| Mayo Clinic Center for Clinical Proteomics | NIH | National Cancer Institute | 2022 to 2025 | $4,271,766 | June 1, 2022 | May 31, 2027 | PANDEY, AKHILESH | reporter.nih.gov |
| Rates and mechanisms of age-related somatic mutation in normal and Alzheimer brain | NIH | National Institute on Aging | 2021 to 2025 | $4,268,929 | April 1, 2021 | September 30, 2026 | WALSH, CHRISTOPHER A. | reporter.nih.gov |
| Retinoids in Vision | NIH | National Eye Institute | 2021 to 2025 | $4,266,288 | August 1, 1992 | August 31, 2028 | PALCZEWSKI, KRZYSZTOF | reporter.nih.gov |
| Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,258,583 | August 20, 2020 | June 30, 2026 | D'ARMIENTO, JEANINE M | reporter.nih.gov |
| Aerosolized Vitamin A: Developing a Prevention for Hyperoxic Lung Injury and Bronchopulmonary Dysplasia, with Focus on Neonatal Lung Maturation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,252,869 | July 1, 2018 | February 28, 2027 | GELFAND, CRAIG | reporter.nih.gov |
| Live cell reporters of genetic changes in stiff vs soft surroundings - Causes & Consequences | NIH | National Cancer Institute | 2021 to 2025 | $4,251,467 | April 1, 2021 | March 31, 2026 | DISCHER, DENNIS E. | reporter.nih.gov |
| A selective angiogenesis blocker to treat retinopathy of prematurity | NIH | National Eye Institute | 2021 to 2023 | $4,248,825 | February 1, 2019 | December 31, 2025 | LI, WEI | reporter.nih.gov |
| Inflammation and Fibrosis in Pulmonary TB: the INFIN-TB Study | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,248,593 | July 1, 2025 | June 30, 2027 | AULD, SARA | reporter.nih.gov |
| Preventing TB with intravenous BCG in SIV-infected macaques | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,248,442 | May 5, 2021 | April 30, 2026 | SCANGA, CHARLES A. | reporter.nih.gov |
| Dystonia Coalition | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $4,243,735 | September 30, 2009 | August 31, 2025 | JINNAH, HYDER A | reporter.nih.gov |
| COBRE Phase 2: Center for Neuroplasticity at the University of Puerto Rico | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $4,239,752 | July 1, 2022 | June 30, 2023 | LASALDE-DOMINICCI, JOSE ANTONIO | reporter.nih.gov |
| Patient Navigation for Improving Transition Success Among Multiply Disadvantaged Young Adult Survivors of Childhood Cancer | NIH | National Cancer Institute | 2025 | $4,236,812 | September 10, 2025 | August 31, 2029 | FREYER, DAVID R | reporter.nih.gov |
| Comprehensive Characterization of the T-cell Response to KSHV to Enable Specific Immune Therapy | NIH | National Cancer Institute | 2025 | $4,234,248 | September 19, 2025 | August 31, 2029 | WARREN, EDUS HOUSTON | reporter.nih.gov |
| Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,229,195 | September 1, 2021 | August 31, 2027 | SATTLER, RITA | reporter.nih.gov |
| Progressive Multifocal Leukoenephalopathy: Endemic Viruses and Lethal Brain Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,225,016 | May 1, 2020 | April 30, 2028 | ATWOOD, WALTER J | reporter.nih.gov |
| Body Composition and Energy Expenditure in Youth with Spina Bifida | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $4,224,862 | July 1, 2019 | November 30, 2025 | POLFUSS, MICHELE | reporter.nih.gov |
| Molecular Regulation of Progressive Pulmonary Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,220,741 | March 1, 2020 | February 28, 2027 | NOBLE, PAUL WESLEY | reporter.nih.gov |
| : Clinical Outcomes in Aicardi Goutières Syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $4,216,994 | July 1, 2019 | June 30, 2025 | VANDERVER, ADELINE LUCIE | reporter.nih.gov |
| An investigation of Alzheimer's Disease pathology, microglial immune response, and CSF proteomics in normal pressure hydrocephalus patients | NIH | National Institute on Aging | 2021 to 2025 | $4,208,639 | September 1, 2021 | May 31, 2027 | TEICH, ANDREW FRANKLIN | reporter.nih.gov |
| The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,208,331 | June 1, 2020 | July 31, 2030 | SESHADRI, CHETAN | reporter.nih.gov |
| The Long-Acting/Extended Release Antiretroviral Resource Program (LEAP) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,204,220 | May 15, 2015 | June 30, 2030 | FLEXNER, CHARLES W. | reporter.nih.gov |
| The origin, the function and the phenotypic impact of human alleles | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,194,794 | May 11, 2018 | August 31, 2028 | SUNYAEV, SHAMIL | reporter.nih.gov |
| Capturing spatial patterns of new M. tuberculosis infection in Kampala, Uganda | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,188,624 | August 9, 2019 | July 31, 2026 | BARK, CHARLES MARTYN | reporter.nih.gov |
| Evaluating Assessment and Medication Treatment of ADHD in Children with Down Syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $4,182,561 | May 1, 2024 | August 31, 2025 | ESBENSEN, ANNA J. | reporter.nih.gov |
| MSC Exosome Treatment for BPD: Impact on Immunity and Lung Development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,182,213 | March 1, 2019 | February 28, 2027 | KOUREMBANAS, STELLA | reporter.nih.gov |
| Neuronal and Network Mechanisms of Electrocortical Stimulation | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $4,175,793 | August 15, 2023 | July 31, 2026 | SLUTZKY, MARC W. | reporter.nih.gov |
| Comparative Modeling for the Prevention and Control of Uterine Cancer | NIH | National Cancer Institute | 2021 to 2025 | $4,171,414 | September 17, 2021 | August 31, 2026 | WRIGHT, JASON | reporter.nih.gov |
| Metabolic reprogramming of the tumor microenvironment and therapy resistance | NIH | National Cancer Institute | 2021 to 2025 | $4,171,362 | August 17, 2021 | July 31, 2028 | LENGYEL, ERNST | reporter.nih.gov |
| Structural Analysis and Inhibitor Optimization of Cryptosporidium n-myristoyltransferase for Drug Discovery | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,163,372 | November 15, 2020 | October 31, 2026 | STAKER, BART LEE | reporter.nih.gov |
| Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $4,152,012 | February 1, 2023 | January 31, 2027 | KHADER, SHABAANA A. | reporter.nih.gov |
| STRUCTURAL VARIATION IN NEUROLOGICAL DISEASE | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,141,654 | December 15, 2017 | November 30, 2026 | LUPSKI, JAMES R. | reporter.nih.gov |
| Mechanisms of Synaptic Transmission in Healthy and Disease States | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,140,156 | May 1, 2019 | April 30, 2027 | KLYACHKO, VITALY A | reporter.nih.gov |
| Development of N-tert-(butyl)hydroxylamine (NtBuHA) as a therapeutic agent for treating CLN1 Batten Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,136,457 | September 20, 2021 | June 30, 2027 | CHELSKY, DANIEL | reporter.nih.gov |
| Development of mRNA-platform vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,121,318 | January 21, 2021 | December 31, 2026 | DAMRON, FREDRICK HEATH | reporter.nih.gov |
| Mechanisms of Helicases, Translocases and SSB Proteins involved in Genome Maintenance | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,120,970 | May 1, 2020 | July 31, 2030 | LOHMAN, TIMOTHY M | reporter.nih.gov |
| Integrating human and non-human primate data to understand the acquisition of pre-erythrocytic immunity in the face of previous malaria exposure | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,114,200 | February 10, 2022 | January 31, 2027 | WILDER, BRANDON KEITH | reporter.nih.gov |
| The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL) | NIH | National Cancer Institute | 2022 to 2025 | $4,109,575 | September 8, 2022 | August 31, 2027 | SLAGER, SUSAN L | reporter.nih.gov |
| Molecular Prediction of Myeloma Initiation Molecular Prediction of Myeloma Initiation | NIH | National Cancer Institute | 2022 to 2025 | $4,108,272 | September 6, 2022 | August 31, 2029 | GHOBRIAL, IRENE M. | reporter.nih.gov |
| New chemotherapy regimens and biomarkers for Chagas disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,104,835 | August 17, 2018 | July 31, 2025 | ALMEIDA, IGOR C | reporter.nih.gov |
| Development of an oral liver-targeted prime-and-trap malaria vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,104,491 | December 1, 2020 | November 30, 2026 | MURPHY, SEAN C | reporter.nih.gov |
| Altered metabolism and machine learning for pancreatic cancer early detection | NIH | National Cancer Institute | 2021 to 2025 | $4,100,528 | September 16, 2022 | August 31, 2027 | WOLPIN, BRIAN MATTHEW | reporter.nih.gov |
| Stromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity | NIH | National Cancer Institute | 2022 to 2025 | $4,096,241 | September 19, 2022 | August 31, 2027 | HAHN, WILLIAM C. | reporter.nih.gov |
| Multi-racial genetic analysis of hidradenitis suppurativa | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $4,095,633 | July 16, 2021 | June 30, 2026 | LIAO, WILSON | reporter.nih.gov |
| Optimization of an in vivo base editing strategy to treat SOD1-linked ALS | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $4,091,010 | July 25, 2025 | November 30, 2026 | GAJ, THOMAS | reporter.nih.gov |
| A STINGing vaccine for TB | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,090,805 | June 1, 2020 | May 31, 2026 | BISHAI, WILLIAM RAMSES | reporter.nih.gov |
| Pain Mechanisms in Fabry Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,085,512 | May 15, 2019 | March 31, 2026 | STUCKY, CHERYL LOUISE | reporter.nih.gov |
| Initiation of Diffuse and Intestinal Non-Cardia Gastric Cancer | NIH | National Cancer Institute | 2022 to 2025 | $4,080,056 | September 1, 2025 | August 31, 2027 | RYEOM, SANDRA | reporter.nih.gov |
| PET-MR Imaging of pulmonary fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,079,636 | July 1, 2021 | June 30, 2026 | CARAVAN, PETER D | reporter.nih.gov |
| Childhood Omics and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $4,076,080 | April 22, 2020 | August 31, 2025 | CATTAMANCHI, ADITHYA | reporter.nih.gov |
| Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2025 | $4,072,882 | September 1, 2017 | July 31, 2028 | GOEL, AJAY | reporter.nih.gov |
| Translating Pediatric Cancer Proteogenomic Data into Biological and Clinical Insights | NIH | National Cancer Institute | 2022 to 2025 | $4,071,173 | June 1, 2022 | May 31, 2027 | ZHANG, BING | reporter.nih.gov |
| Parasitic Ulcer Treatment Trial | NIH | National Eye Institute | 2023 to 2025 | $4,068,111 | September 30, 2023 | March 31, 2028 | KEENAN, JEREMY DAVID | reporter.nih.gov |
| Optimization of Lead BKIs for Cryptosporidiosis Therapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,065,300 | January 1, 2021 | December 31, 2026 | VAN VOORHIS, WESLEY C | reporter.nih.gov |
| Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,065,243 | March 15, 2021 | February 28, 2027 | DEBAUN, MICHAEL R. | reporter.nih.gov |
| Diversity supplement for noninvasive, wireless thermal sensors for the quantitative monitoring of ventricular shunt function in patients with hydrocephalus | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $4,059,841 | September 15, 2021 | August 31, 2024 | SOMERA, ANNA LISA | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| University of California Los Angeles | Los Angeles, CA | 212 | $825.5 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 507 | $741.5 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 464 | $611.7 million | 0 | $0 |
| Fred Hutchinson Cancer Center | Seattle, WA | 120 | $601.7 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 333 | $540.4 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 442 | $521.1 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 344 | $496.1 million | 0 | $0 |
| Stanford University | Stanford, CA | 388 | $460.5 million | 0 | $0 |
| Washington University | Saint Louis, MO | 414 | $431.9 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 398 | $423.7 million | 0 | $0 |
| Yale University | New Haven, CT | 309 | $372.8 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 345 | $364.6 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 289 | $359.1 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 286 | $357.9 million | 0 | $0 |
| Emory University | Atlanta, GA | 317 | $343.7 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 273 | $332.8 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 296 | $332 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 50 | $317.2 million | 0 | $0 |
| University of Washington | Seattle, WA | 233 | $315.6 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 181 | $314.2 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 185 | $304.2 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 179 | $297.2 million | 0 | $0 |
| Duke University | Durham, NC | 276 | $283.2 million | 0 | $0 |
| Dana-Farber Cancer Inst | Boston, MA | 186 | $280.1 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 196 | $267.6 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 162 | $263.7 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 233 | $253.2 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 235 | $248.8 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 188 | $244.9 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 228 | $243.6 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 161 | $240.4 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 198 | $237.3 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 236 | $234.2 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 147 | $230.6 million | 0 | $0 |
| ST. Jude Children's Research Hospital | Memphis, TN | 143 | $230.5 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 195 | $229 million | 0 | $0 |
| Ohio State University | Columbus, OH | 185 | $215.4 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 97 | $211.3 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 164 | $211 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 147 | $209.9 million | 0 | $0 |
| University of Florida | Gainesville, FL | 195 | $207.5 million | 0 | $0 |
| Public Health Institute | Oakland, CA | 6 | $185.8 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 171 | $182.6 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 148 | $180.2 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 193 | $173.3 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 162 | $168.3 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 121 | $161.2 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 153 | $155.8 million | 0 | $0 |
| University of Chicago | Chicago, IL | 122 | $151.7 million | 0 | $0 |
| Beckman Research Institute/city of Hope | Duarte, CA | 108 | $150.6 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 116 | $150.4 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 91 | $142.2 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 133 | $142 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 133 | $140.9 million | 0 | $0 |
| University of California at Davis | Davis, CA | 141 | $134.7 million | 0 | $0 |
| Research Inst Nationwide Children's Hosp | Columbus, OH | 78 | $132.9 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 96 | $122.7 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 119 | $119.2 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 103 | $118.1 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 98 | $116.8 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 104 | $113.4 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 78 | $111.4 million | 0 | $0 |
| University of Texas Med BR Galveston | Galveston, TX | 79 | $106.5 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 97 | $103.5 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 85 | $102.7 million | 0 | $0 |
| H. Lee Moffitt Cancer CTR & Res Inst | Tampa, FL | 69 | $100.2 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 52 | $99.8 million | 0 | $0 |
| University of Rochester | Rochester, NY | 78 | $96.3 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 85 | $94.7 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 62 | $93.9 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 73 | $88.7 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 95 | $88 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 77 | $87.6 million | 0 | $0 |
| Thomas Jefferson University | Philadelphia, PA | 77 | $79.5 million | 0 | $0 |
| Dartmouth College | Hanover, NH | 45 | $77.4 million | 0 | $0 |
| Colorado State University | Fort Collins, CO | 59 | $72.1 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 59 | $68 million | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 81 | $66.9 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 52 | $64.7 million | 0 | $0 |
| University of Cincinnati | Cincinnati, OH | 76 | $63.7 million | 0 | $0 |
| Vanderbilt University | Nashville, TN | 87 | $63.7 million | 0 | $0 |
| Mayo Clinic Jacksonville | Jacksonville, FL | 49 | $62.3 million | 0 | $0 |
| ST. Joseph's Hospital and Medical Center | Phoenix, AZ | 12 | $61.7 million | 0 | $0 |
| Broad Institute, Inc. | Cambridge, MA | 38 | $61.7 million | 0 | $0 |
| Children's Research Institute | Washington, DC | 60 | $61.2 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 76 | $60.8 million | 0 | $0 |
| Rockefeller University | New York, NY | 40 | $60.4 million | 0 | $0 |
| Harvard Medical School | Boston, MA | 91 | $59 million | 0 | $0 |
| University of Missouri-Columbia | Columbia, MO | 62 | $58.5 million | 0 | $0 |
| George Washington University | Washington, DC | 36 | $57.3 million | 0 | $0 |
| Massachusetts Institute of Technology | Cambridge, MA | 58 | $57.2 million | 0 | $0 |
| Lurie Children's Hospital of Chicago | Chicago, IL | 47 | $57.1 million | 0 | $0 |
| NRG Oncology Foundation, Inc. | Philadelphia, PA | 1 | $54.3 million | 0 | $0 |
| University of Georgia Research Foundation Inc | Athens, GA | 69 | $53.9 million | 0 | $0 |
| La Jolla Institute for Immunology | La Jolla, CA | 19 | $51 million | 0 | $0 |
| Pennsylvania State Univ Hershey Med CTR | Hershey, PA | 51 | $50.8 million | 0 | $0 |
| Georgetown University | Washington, DC | 46 | $50.7 million | 0 | $0 |
| Children's Hospital of Los Angeles | Los Angeles, CA | 41 | $50.5 million | 0 | $0 |
| University of Hawaii | Honolulu, HI | 22 | $49.8 million | 0 | $0 |
| Brown University | Providence, RI | 37 | $49.5 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 8,956 | $5,314,897,629 | 0 | $0 |
| 2024 | 9,454 | $5,118,360,101 | 0 | $0 |
| 2023 | 9,549 | $5,223,583,252 | 0 | $0 |
| 2022 | 9,642 | $5,168,328,544 | 0 | $0 |
| 2021 | 9,570 | $4,808,209,727 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.